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ABSTRACT OF THE DISSERTATION
Multi-omic Understanding of the Evolution of Xenobiotic Tolerance in Bacterial Isolates and
Communities
by
Tayte P. Campbell
Doctor of Philosophy in Biology and Biomedical Sciences
Plant and Microbial Biosciences
Washington University in St. Louis, 2019
Professor Gautam Dantas, Chair
Xenobiotic compounds are any chemicals that are released into an environment by human
action and that occur at concentrations higher than found naturally. Xenobiotics, including
aromatic compounds and antibiotics, are recalcitrant to degradation because they are often toxic
or mutagenic. Despite this toxicity, bacteria account for a large portion of xenobiotic degradation
in the environment. Bacteria are able to adapt to these foreign chemicals, gaining increased levels
of tolerance and increased rates of xenobiotic degradation. On the strain level, increased tolerance
can be caused by mutations in individual cells or through the acquisition of genes from other cells.
At the community level, xenobiotics select for naturally resistant bacterial often resulting in an
increase in genes involved with xenobiotic tolerance. The goal of my thesis was to (1) understand
how bacterial strains evolve increased tolerance to toxic aromatics xenobiotics through adapted
evolution and (2) how microbial communities in mammalian guts are altered due to xenobiotic
selection pressure.
To determine the microbial adaptations that occur in bacterial strains exposed to
xenobiotics, I studied the changes that occurred in the genome and transcriptome of Rhodococcus

ix

opacus PD630 when grown over several generations on increasing concentrations of toxic
aromatic compounds. Chemical pretreatment of lignocellulose as a first step in biofuel production
results in the creation of monomeric sugars and toxic xenobiotic compounds. Bacterial conversion
of the resulting moiety to biofuel precursors is one of the most cost-effective methods of biofuel
production. However, the toxic aromatic compounds created from lignocellulose pretreatment
inhibit bacterial growth and reduce overall productivity. R. opacus is a bacterial strain that
naturally has a high tolerance to aromatic compounds and optimization of this bacteria can improve
process efficiency. By analyzing 35 R. opacus strains adapted on 6 different compounds or
compound mixtures, I show that adapted strains demonstrated up to 1900% improvement in final
cell densities. I found no mutations in xenobiotic degradations genes for the adapted strains, but I
found several mutations in genes that are involved with oxidation-reduction reactions that may
assist in degradation. These results demonstrate that bacterial strains can gain increased xenobiotic
tolerance by fine-tuning metabolic pathways indirectly related to xenobiotic degradation.
To determine the effects of xenobiotic selection on microbial communities, I studied the
gut microbiome of humans, captive chimpanzees, and captive gorillas that have received antibiotic
treatment compared to the microbiome of wild chimpanzees and gorillas that have never received
antibiotic treatment. I found that antibiotic treatment was correlated with higher richness and
abundance of antibiotic resistance genes. In addition, the microbiome and resistome in captive
apes were more similar to that of humans than to the wild apes, despite differences in host species
and large geographic distances between the human and captive apes. Together, these results
suggest that host lifestyle, including diet and antibiotic treatment, is more influential in
microbiome composition than host species and geographic proximity. I also identified a number
of novel antibiotic resistance genes for which further investigation is warranted.

x

Chapter 1

Introduction
1.1 Xenobiotics
Xenobiotics have been produced in enormous quantities over the past century as a result of
industrial activity [1]. In a broad sense, xenobiotics are any compounds that are foreign to the
natural environment or found at much higher concentrations than usual [2]. They may either be
artificially synthesized (e.g. chlorinated biphenyls, alkylbenzyl sulphonates, and halocarbons),
natural products used at high concentrations (e.g. most antibiotics), or created by incomplete
combustion of organic materials (e.g. phenolics and polycyclic aromatic hydrocarbons (PAHs))
[3-6]. Xenobiotic compounds are often toxic and recalcitrant to biodegradation, leading to
contamination of the environment and bioaccumulation in living organisms [7]. Bacterial
degradation of xenobiotics can be harnessed to either degrade unwanted pollutants to harmless
byproducts through bioremediation, or to convert abundant xenobiotics to value added chemicals
[8, 9]. In the case of antibiotics, targeted xenobiotic toxicity is utilized to kill pathogenic microbes
in host organisms without harming the host [10]. However, microorganisms are becoming more
resistant to antibiotics and increasingly able to metabolize antibiotic compounds to harmless
byproducts [11, 12]. Understanding the microbial processes necessary for xenobiotic tolerance and
degradation will allow for the engineering of improved bacterial strains for bioremediation and
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industrial production, while also providing key insight to combat the spread of antibiotic
resistance.

1.2 Mechanisms of Xenobiotic Toxicity
Many aromatic xenobiotics cause toxicity through the formation of quinones in the cell
[13]. Quinones, fully conjugated cyclic compounds, are toxic due to the creation of free radicals
that react with cell components [13, 14]. For example, free radicals damage cells by causing DNA
mutations and by oxidizing lipids, amino acids, and carbohydrates [15, 16]. Quinones are
particularly toxic because when they interact with cellular enzymes it leads to a phenomenon
termed futile redox cycling. Specifically, futile redox cycling occurs when a cytochrome-P450
reductase uses NADPH to reduce a quinone to semiquinone by adding one electron [17]. The
resulting semiquinone rapidly reacts to produce a superoxide anion by passing the radical electron
onto an oxygen molecule resulting in the formation of the original quinone, restarting the cycle
[13]. The generated superoxide anion can then damage cell components with its highly reactive
electron radical. Futile cycling thus leads to a rapid increase in harmful radical species within the
cell while also depleting NADPH reservoirs within the cell [18]. Xenobiotics that cause toxicity
through this mechanism are typically toxic to both prokaryotic and eukaryotic cells due to the nonspecific nature of free radical reactions [19].
In contrast, antibiotic compounds are targeted to specific cell types and typically bind to
targeted proteins or lipids [20]. This specific activity allows for their use to clear bacterial
infections in humans and animals without causing harm to host cells and tissues [10, 21, 22].
Antibiotics target cellular components that are conserved across the bacterial domain of life and
that are either absent or sufficiently different in host cells [23]. Current antibiotics only target a
small number of cellular components and pathways such as bacterial ribosomes, lipid membranes,
2

the cell wall synthesis pathway, the folate synthesis pathway, and proteins involved in DNA
replication and maintenance [24]. Antibiotics bind to specific proteins and lipids resulting in
inhibition of the protein activity when bound to the former or, when bound to the latter, disruption
of the cell membrane.

1.3 Xenobiotic Tolerance
Bacterial tolerance to xenobiotic compounds in individual isolates is typically achieved
through one of four common mechanisms: 1) xenobiotic degradation or modification, 2) alteration
or protection of the xenobiotic target, 3) active efflux of the xenobiotic, or 4) reduced permeability
of the xenobiotic into the cell [10]. Since these resistance mechanisms cause resistance in different
ways, the presence of more than one in a cell can result in higher levels of resistance [25]. For
example, if a bacterial strain encodes both a xenobiotic degradation enzyme and has reduced
permeability, then fewer xenobiotic compounds enter the cell and those that do are degraded [25].
When one mechanism becomes oversaturated, the other mechanism can compensate and keep
xenobiotic concentrations low within the cell. In fact, multiple resistance mechanisms may be
necessary for tolerance if both mechanisms have low specificity to the xenobiotic [25].
Bacterial enzymes have evolved over millennia to metabolize substrates that are commonly
found in their natural environment [26]. Since xenobiotic compounds contain uncommon chemical
structures or properties, bacteria often don’t intrinsically have enzymes that are capable of their
degradation [27]. However, upon exposure to these unnatural compounds, bacteria are able to
adapt relatively quickly and increase their levels of tolerance and degradation [28]. In fact,
communities pre-exposed to specific xenobiotics or structurally similar compounds are able to
increase their degradation rates up to 1,000-fold higher than unexposed populations [29]. Bacteria
are able to adapt by either acquiring necessary genes from other bacteria through a mechanism
3

termed horizontal gene transfer or through acquired mutations that alter enzymatic specificities or
create novel metabolic activities [2, 26].
In complex microbial communities, xenobiotic exposure selects for bacterial species that
are able to tolerate the xenobiotic [26, 30]. One typical result of this selection pressure is reduced
richness and diversity in bacterial communities as non-tolerant strains are often eliminated [31].
Another complication is that of these tolerance mechanisms, only microbial degradation reduces
the amount of xenobiotic in the environment. As a result, degradation benefits bacteria with other
resistance mechanisms and even bacteria that would otherwise be susceptible to the xenobiotic.
These bacteria are termed cheaters since they benefit from the activity of other organisms [32].
This can lead to interesting community dynamics when the fitness cost of maintaining resistance
genes is higher than the fitness cost of antibiotic susceptibility [33]. Paradoxically, the end result
of this is selection against the individual strains that are performing xenobiotic degradation. Due
to this wide array of community responses, it’s necessary to analyze the taxonomic changes along
with the xenobiotic tolerance mechanisms in the community to begin to tease apart the community
dynamics associated with xenobiotic selection pressure. DNA sequencing of microbial
communities allows for both the identification of bacterial taxa and individual genes [34-36].
However, in complex microbial communities it can be difficult to associate specific genes with
their host species, especially with the short DNA sequencing reads that are common today. With
these limitations, correlational findings can be inferred statistically but may need longer
sequencing lengths and co-culturing of simplified communities to further elucidate these
dynamics.

1.4 Lignocellulose Degradation for Biofuel Production
4

Even though biological process may occur at very slow rates, microbial conversion of
xenobiotics provides a cost effective solution for bioremediation or industrial conversion processes
[37, 38]. For example, lignocellulosic biomass, the most abundant biological compound on the
planet, is often targeted for biological conversion to biofuels [39]. Lignocellulose is comprised of
three main components: cellulose, hemicellulose, and lignin. Cellulose, and to a lesser extent
hemicellulose, are easily depolymerized through enzymatic degradation into their component
sugar molecules [40]. Lignin, on the other hand, is a complex aromatic compound that is resistant
to degradation by microorganisms [41]. Due to its recalcitrance, the lignin fraction is often
discarded or burned to produce process heat or on-site electricity generation [42]. However,
techno-economic analyses have identified the co-utilization of lignin as an important factor for the
production of cost effective biofuels [43]. To aid in lignin degradation, lignin is often
thermochemically depolymerized, resulting in toxic xenobiotics such as vanillic acid, catechol,
carboxylic acids, and phenolic compounds that inhibit bioconversion [40, 41]. Research is
currently underway to engineer a microbial strain, either through adaptive evolution or rational
design, that is tolerant of and can degrade these xenobiotic compounds, thus increasing
bioconversion productivity and yield [44].
My first objective in this thesis was to characterize the evolution of xenobiotic tolerance in
a single bacterial strain after several generations of adaptive evolution to aromatic compounds. To
evaluate this, we conducted adaptive evolution on Rhodococcus opacus PD630 (hereafter R.
opacus) over several generations using various lignin-derived model compounds. R. opacus is a
soil bacteria isolated from contaminated soil at a gasworks plant that has a naturally high tolerance
for aromatic compounds [45]. Through adaptive evolution we increased the xenobiotic tolerance
of R. opacus up to 1900% on several phenolic compounds and their mixtures. Using comparative
5

genomics of these adapted strains compared to the wild type strain, we identified genetic mutations
and changes in gene expression levels that contribute to xenobiotic tolerance at the strain level.

1.5 Antibiotic Resistance in Gut Microbial Communities
Not all xenobiotic tolerance is useful from an anthropogenic viewpoint. Microbial
resistance to antibiotics is quickly becoming a major public health problem [46]. Even though
antibiotic resistance pre-dates mass production of antibiotics, widespread use of antibiotics has
selected for an increased abundance of antibiotic resistance genes (ARGs) in environmental and
human microbiomes [47-50]. Antibiotic resistance in bacteria is particularly troubling due to the
fact that adaptive evolution is working against us, i.e. extensive treatment with antibiotics results
in a higher abundance of ARGs and increased tolerance [51]. Thus, the only way to combat
antibiotic resistance, besides continually designing new families of antibiotics, is to prevent the
spread of plasmid-borne ARGs and develop ARG inhibitors that can rescue antibiotic potency
[52]. Identifying ARGs before they are acquired and widely disseminated by pathogens is crucial
to this effort and provides much needed time to develop ARG inhibitors [53, 54].
The second objective of my thesis was to examine the gut microbial community in humans
and great apes along a gradient of Westernization. We compared the gut microbiome and resistome
of wild chimpanzees and gorillas living in Nouabalé-Ndoki National Park in the Republic of the
Congo, humans living just outside the park, and captive chimpanzees and gorillas from the St.
Louis Zoo (USA) and the Lincoln Park Zoo (Chicago, USA). With this cohort we can investigate
the differences in taxonomy and the abundance and richness of ARGs that occur in the gut
microbiome in cohorts with and without antibiotic exposure. Finally, by using functional
metagenomics we are able to identify novel ARGs that are present in these samples for further
characterization.
6

Chapter 2

Multi-omic elucidation of aromatic
catabolism in adaptively evolved
Rhodococcus opacus
Collaboration Statement
This work was performed in a collaboration between William R. Henson, Tayte P.
Campbell, Drew M. DeLorenzo, Yu Gao, Bertram Berla, Soo Ji Kim, Marcus Foston, Tae Seok
Moon, and Gautam Dantas. M.F., T.S.M., and G.D. conceived the proect. W.R.H, T.P.C, D.M.D,
Y.G., B.B., and S.J.K performed experiments. W.R.H., T.P.C, D.M.D, T.S.M, and GD analyzed
the results. W.R.H, T.P.C, D.M.D, M.F, T.S.M, and G.D wrote the manuscript.

2.1 Abstract
Lignin utilization has been identified as a key factor in biorefinery profitability. However,
lignin depolymerization generates heterogeneous aromatic mixtures that inhibit microbial growth
and the conversion of lignocellulose to biochemicals. Rhodococcus opacus is a promising
aromatic-catabolizing, oleaginous bacterium, but mechanisms for its aromatic tolerance and
utilization remain undercharacterized. To better understand these mechanisms, we adaptively
evolved R. opacus for improved utilization of 32 combinations of diverse aromatic compounds.
7

Evolved R. opacus mutants showed up to 1900% growth improvement in the utilization of phenol,
guaiacol, 4-hydroxybenzoate, vanillate, and benzoate compared to the wild-type strain. Whole
genome sequencing revealed several redox-related genes with mutations shared across multiple
adapted mutants. PVHG6, the mutant with the most improved growth on a mixture of multiple
aromatic compounds, showed 56% lower superoxide dismutase activity than the wild-type strain,
suggesting that redox reactions are important for aromatic tolerance and utilization. Comparative
transcriptomics revealed by-product detoxification pathways and five aromatic funneling
pathways that were upregulated in response to specific aromatic compounds. Gene knockout
experiments confirmed the two degradation routes of the β-ketoadipate pathway for five aromatic
compounds. These results provide an improved understanding of aromatic bioconversion and
facilitate development of R. opacus as a biorefinery host.

2.2 Introduction
Lignocellulosic biomass is a potential source of renewable bio-based fuels and chemicals.
A large fraction of lignocellulose (~ 70–85%) is cellulose and hemicellulose, which can be
depolymerized into monomeric sugars, such as glucose and xylose [55, 56]. The remaining 15–
30% of lignocellulose is lignin, a highly cross-linked, heterogeneous, and recalcitrant aromatic
polymer [57]. Microbial conversion of lignocellulose holds promise as a new way to produce a
variety of novel products and petrochemical replacements (e.g., drop-in fuels) [58-67]. Current
biomass pretreatment approaches, which aim to increase sugar extractability from lignocellulose,
also release aromatics from lignin that negatively affect microbial product titers, yields, and
productivities [41, 68]. Current processes separate the carbohydrate fraction from the lignin
fraction, and the separated lignin is either discarded or burned for process heat or on-site electricity
generation [69]. However, removal of lignin-derived inhibitors from sugar streams is still
8

challenging and costly, and techno-economic analyses have identified the co-utilization of lignin
as an important factor in biorefinery profitability [43, 70]. Therefore, efforts are underway to
develop microbial strains that can tolerate and convert inhibitory, lignin-derived compounds into
value-added products [71-80].
Rhodococcus opacus PD630 (hereafter R. opacus) is a promising bacterial strain for
producing valuable products from lignocellulose. R. opacus is a gram-positive soil bacterium that
has been shown to have an inherently high tolerance to aromatic compounds [45, 81]. Additionally,
it accumulates high levels (up to ~78% as cell dry weight) of the biofuel precursor triacylglycerol
(TAG) and demonstrates a moderately high growth rate [45, 82]. R. opacus can natively consume,
or has been engineered to consume, hexose and pentose sugars present in lignocellulosic
feedstocks [82, 83]. R. opacus can also consume aromatic compounds found in depolymerized
lignin, such as phenol, 4-hydroxybenzoate, and vanillate [84-86], making it uniquely qualified to
utilize all three primary depolymerized components of lignocellulose.
The co-consumption of mixtures of lignin-derived aromatic monomers is an underexplored
area of study that is important for microbial lignin conversion strategies. The inherent
heterogeneity of lignin is a major barrier to lignin valorization, and economical strategies require
rapid conversion of complex aromatic mixtures to products [87-90]. Microbial degradation of
diverse aromatic compounds is typically accomplished by biological funneling, where compounds
are converted into common metabolites (e.g., catechol and proto-catechuate), prior to their
catabolism via a central aromatic degradation pathway, such as the β-ketoadipate pathway [87,
91]. However, interactions between similarly structured compounds and different aromatic
degradation pathways are not well understood in bacteria. Additionally, cross tolerance between
lignin-derived aromatics has not been studied in R. opacus, although it is thought that low
9

concentrations of multiple inhibitory compounds can negatively affect bacterial growth more than
high concentrations of a single inhibitory compound on its own [92].
The underlying mechanisms for aromatic tolerance and utilization in R. opacus, and
microbes in general, are not well understood due to the complexity of the phenotype, which limits
the use of rational strain engineering. One methodology for improving aromatic tolerance is
through adaptive evolution, where evolutionary selection pressure is applied to the organism
through serial subcultures [93, 94]. R. opacus has been demonstrated to be amenable to adaptation
for improved growth in the presence of different inhibitors from lignocellulosic hydrolysates (e.g.,
furans, organic acids, and phenolics) [92], but the mechanistic basis for these improvements are
unknown. Our previous work showed that R. opacus could be adapted for improved growth and
lipid production on the lignin model compound phenol as a sole carbon source [86], and we
identified the upregulation of aromatic degradation pathways and transporters as potential
mechanisms of improvement in the adapted strains. However, phenol is only one of many potential
aromatic compounds from lignin [88-90], and additional research is required to understand R.
opacus’ ability to adapt to mixtures of lignin-derived model compounds.
In this work, R. opacus was adaptively evolved on 32 combinations of six lignin model
compounds (without added sugars) to study the capacity to improve its aromatic tolerance and
utilization (Figure 2-1). Comparative genomic analysis of 35 improved adapted strains identified
a high percentage of mutations in oxidation and reduction (redox) related genes, several of which
were shared across multiple strains from different adaptation conditions. We demonstrated that the
activity of one of these targeted enzymes, superoxide dismutase, was 56% lower in PVHG6 (a
mutant adapted for improved growth on a mixture of multiple compounds) than the wild-type
(WT) strain. This suggests that reactive oxygen species may be important for aromatic tolerance
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Figure 2-1: Experimental Approach. (A) R. opacus PD630 was serially passaged on lignin
model compounds and high glucose (33 conditions). Six adapted cultures were selected for further
characterization: four using phenol and up to three other lignin model compounds, one using
sodium benzoate, and one using high glucose as carbon sources. (B) Six colonies from the selected
adapted cultures were phenotyped in adaptation growth conditions to determine improvement
compared to the WT strain. Strains with improved growth (OD600) compared to the WT strain were
characterized by whole genome sequencing and growth assays using mixtures of lignin model
compounds. (C) The best-performing adapted strain (PVHG6) and the WT strain were further
characterized using RNA-Seq and targeted metabolomic analyses to identify mechanisms for
improved lignin model compound tolerance and utilization. Lipid titers were measured to
characterize the adapted strain’s capacity to convert lignin model compounds into lipids.
and utilization. To examine whether aromatics were consumed individually or concurrently,
targeted metabolomics was performed, revealing that compounds were consumed in a distinct
order and that the PVHG6 strain co-consumed lignin model compounds at faster rates than the WT
strain. We performed RNA-Seq on PVHG6 and WT grown on individual lignin model compounds
and their mixture (without added sugars) to elucidate genes and pathways related to aromatic
catabolism. Transcriptomic analyses identified five distinct funneling pathways and two byproduct detoxification pathways, each of which is activated by specific aromatic compounds, as
well as a number of upregulated transporters. Additionally, by gene knockout experiments, we
confirmed the degradation routes of five aromatic compounds and the importance of upregulated
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transporters for growth on aromatic compounds. Lastly, to demonstrate that our improved aromatic
tolerance and utilization phenotypes are compatible with production of valuable products from
lignin, we measured lipid production and observed a 225% increase in lipid titer with the PVHG6
strain relative to the WT strain when grown on 2.5 g/L total aromatics as a sole carbon source.
Together, these results advance our understanding of aromatic mixture tolerance and catabolism,
which is a critical first step toward future fuel and chemical production from lignocellulose and
establish R. opacus as a promising bioproduction strain.

2.3 Results
2.3.1 Adaptive evolution and characterization of adapted strains
To determine R. opacus’ ability to improve its aromatic tolerance and consumption, we
adaptively evolved it using increasingly higher concentrations of individual lignin model
compounds and combinations of lignin model compounds (a total of 32 conditions without added
sugars, Figure 2-1, Table 2-S1). For comparison to aromatic adaptation experiments, we also
serially passaged R. opacus using high concentrations of glucose. For further analysis, we selected
four adaptation experiments that used one to four different lignin model compounds that included
phenol and other phenolic compounds as carbon sources, as well as two adaptation experiments
that used sodium benzoate (a non-phenolic lignin model compound) and glucose as sole carbon
sources. The adaptation experiments chosen for further characterization were:1) phenol (P); 2)
phenol and vanillate (PV); 3) phenol, vanillate, and 4-hydroxybenzoate (PVH); 4) phenol,
vanillate, 4-hydroxybenzoate, and guaiacol (PVHG); 5) sodium benzoate (B); and 6) high glucose.
Six colonies from each of these six chosen adaptation experiments were isolated, and their growth
was compared to that of the WT strain using their respective adaptation carbon source(s) (Figures
12

2-2, 2-S1). 35 of the 36 isolated strains had significantly higher cell densities (OD 600; up to1900%
improvement) than the WT strain after 43 h of growth on the carbon sources used in their
adaptation. Aromatic consumption pat-terns for adapted strains after 43 h of growth suggest that
improved growth of these strains is due to both consumption of and tolerance to aromatic carbon
sources (Figure 2-S2). These results demonstrate that R. opacus can be adaptively evolved to
improve growth on different combinations of lignin model compounds.

Figure 2-2: Growth of the WT strain and adapted strains using adaptation carbon sources.
Bars represent OD600 values measured at 43 h of growth in minimal medium A supplemented with
the listed carbon sources and 1 g/L ammonium sulfate as the nitrogen source. (A) The PHE adapted
strains (P1-6) compared to the WT strain using 1.1 g/L PHE. (B) The PHE and VAN adapted
strains (PV1-6) compared to the WT strain using 1.2 g/L PHE and 1.2 g/L VAN. (C) The PHE,
VAN, and HBA adapted strains (PVH1-6) compared to the WT strain using 0.5 g/L PHE, 1 g/L
HBA, and 1 g/L VAN. (D) The PHE, VAN, HBA, and GUA adapted strains (PVHG1-6) compared
to the WT strain using 0.4 g/L GUA, 0.4 g/L PHE, 0.7 g/L HBA, and 0.7 g/L VAN. (E) The BEN
adapted strains (B1-6) compared to the WT strain using 9.4 g/L BEN. (F) The high glucose adapted
strains (Glc1-6) compared to the WT strain using 314 g/L glucose. Bars represent the average of
three biological replicates and error bars represent one standard deviation. PHE = phenol, VAN =
vanillate, HBA = 4-hydroxybenzoate, GUA = guaiacol, and BEN = sodium benzoate.
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2.3.2 Comparative genomics of adapted strains
To identify possible causative mutations for adaption, we examined the 35 isolated strains
with improved growth (Figure 2-2) by whole genome sequencing (> 38× coverage per strain).
Across all 35 strains, genomic analysis revealed a total of 255 distinct SNPs and 6
insertion/deletions (INDELs) distributed over the chromosome and 6 of the 9 endogenous plasmids
[95] (Figure 2-S3, Tables 2-S2–2-S4). Based on sequencing depth, we observed major deletions
in Plasmid 1 for 11 strains from the PVHG, B, and high glucose adaptation experiments, and we
observed complete loss of Plasmid 2 in 25 strains from the P, PV, PVH, PVHG, and B adaptation
experiments (Figure 2-S4). Plasmids 1 and 2 are large plasmids with sizes of 172,218 bp and
97,588 bp, respectively. Growth improvements could result from either deletion of burdensome
genes, reduced replication costs for maintaining large plasmids, or a combination of both [96, 97].
To identify potential common patterns of genetic changes between strains and adaptation
conditions, we classified genes affected by mutations using Gene Ontology (GO) terms [98] and
then further grouped GO terms into broader functional categories (Figure 2-3A). Interestingly,
many genes involved in redox reactions were affected by SNPs after adaptation in phenolic
compound mixtures (Figure 2-3A). On average, 36% of the non-synonymous SNPs in strains
adapted using phenolic compounds, compared to only 16% in strains adapted using non-phenolic
carbon sources (e.g., BEN and glucose), were found in genes related to redox reactions. These
results suggest that the selection pressure applied by adaptive evolution targeted redox reactions
to improve tolerance and utilization of phenolic compounds.
We identified seven genes that were affected by non-synonymous SNPs across multiple
aromatic adaptation experiments (Figure 2-3B, Table 2-S5). Surprisingly, we did not observe any
shared genes whose annotation is related to aromatic degradation. Of the seven genes, three genes
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Figure 2-3: Comparative genomics of lignin model compound adapted strains. (A)
Categorization of genes with non-synonymous SNPs or intergenic SNPs that could affect gene
expression using Gene Ontology (GO) terms organized by strain. Strain names indicate the
adaptation condition from which each strain originated: P = phenol; PV = phenol and vanillate;
PVH = phenol, vanillate, and 4-hydroxybenzoate; PVHG = phenol, vanillate, 4-hydroxybenzoate,
and guaiacol; B = sodium benzoate; and Glc = glucose. (B) Genes with non-synonymous SNPs or
intergenic SNPs that could affect gene expression and that were found across multiple aromatic
adaptation experiments. Putative annotations are from NCBI reference sequence NZ_CP003949.1.
“All” indicates that all sequenced strains isolated from the indicated adaptation condition contain
either non-synonymous SNPs or intergenic SNPs that could affect gene expression. Base Mean
Expression is the average of the normalized counts from WT and PVHG6 transcriptomic data from
all growth conditions.
are annotated to be involved in redox reactions: RS14825 (cytochrome ubiquinol oxidase subunit
I), RS01890 (manganese-dependent superoxide dismutase [SOD]), and RS38570 (a FAD-binding
oxidoreductase). Non-synonymous or intergenic SNPs affecting cytochrome ubiquinol oxidase
and superoxide dismutase were found in at least one strain from all four adaptation experiments
containing phenolic compounds, but not in any strains from the B and high glucose adaptation
experiments. The previous adaptation experiment in R. opacus using phenol [86] also led to a
mutation in cytochrome ubiquinol oxidase. Furthermore, two genes involved in gluconeogenesis
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had non-synonymous SNPs in multiple adaptation lineages: RS08140 (phosphoenolpyruvate
[PEP] carboxykinase) and RS10095 (class II fructose-bisphosphate aldolase). Additionally, two
genes related to phosphorylation had non-synonymous SNPs: RS32480 (phosphotransferase) and
RS39015 (serine/threonine protein kinase).
To investigate the consequence of non-synonymous SNPs in the cytochrome ubiquinol
oxidase and SOD genes further, we modeled the mutational sensitivity (i.e., the probability of the
mutation having a phenotypic effect) using Phyre2 [99] and SuSPect [100]. The modified residues
in the adapted strains for both genes had mutational sensitivities ranging from medium to very
high for the modified amino acids, suggesting that these SNPs could have a phenotypic effect
(either positive or negative; Tables 2-S6, 2-S7) [100]. To verify the modeling results for
superoxide dismutase, we measured the SOD activity using cell lysates from the WT strain and
one of our multi-compound adapted strains with a non-synonymous SNP in SOD (PVHG6). The
adapted PVHG6 strain showed a 56% lower SOD activity compared to that of the WT strain
(Figure 2-S5). This lower activity suggests that the adapted strain is likely to reduce fewer
superoxide radicals than the WT strain, which could contribute to its improved growth in the
mixture of lignin model compounds through their facilitated oxidation [101, 102].

2.3.3 Characterization of adapted strains on lignin model compound mixtures
Efficient microbial lignin valorization requires the utilization of complex aromatic
compound mixtures. Thus, we sought to determine the performance of our aromatic adapted strains
in mixtures of lignin model compounds compared to the WT strain. We hypothesized that the
adapted strains’ improved tolerance phenotype towards a subset of five chosen lignin model
compounds (one to four compounds) could be extended to a mixture of all five compounds. To
test this hypothesis, we grew one strain from each of the P, PV, PVH, PVHG, and B adaptation
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experiments on a mixture of five aromatics (PHE, GUA, HBA, VAN, and BEN). At 2.5 g/L total
aromatics (0.5 g/L of each lignin model com-pound), all five adapted strains had significantly
higher growth rates than the WT strain (P < 0.009 for all adapted strains; Figure 2-4A, Table 2S8). P1, PV1, and PVHG6 strains reached a higher OD600 than the WT strain after 100 h of growth
(P < 0.004 for all three strains), while PVH5 and B2 did not reach significantly higher OD600 values
(Table 2-S8). PVHG6 reached the highest OD600 among all strains after 70 h of growth, which was
96% higher than the WT strain (P = 3.8 × 10−6). At 3.0 g/L total aromatics (0.6 g/L of each
aromatic compound), all strains had significantly higher growth rates than the WT strain (P < 0.03
for all adapted strains; Figure 2-S6, Table 2-S9). P1, PV1, and PVHG6 also reached 75–85%
higher OD600 values than the WT strain after 100 h of growth (P < 0.03 for all three strains), while
PVH5 and B2 did not reach significantly higher OD600 values (Figure 2-S6, Table 2-S9). These
results demonstrate that some adapted strains (P1, PV1, and PVHG6) have improved growth on a
mixture of aromatics, some of which were not used during their adaptation. For the three bestperforming strains (P1, PV1, and PVHG6), the only exclusively shared gene which was affected
by a SNP was SOD (Figure 2-3B), which further supports that SOD may be related to improved
growth on lignin model compounds. Because PVHG6 showed the best growth performance at both
2.5 and 3.0 g/L total aromatics, it was chosen for further characterization.

2.3.4 Aromatic consumption in a lignin model compound mixture by PVHG6
Next, we sought to determine if all lignin model compounds in the five-compound mixture
were used for growth and if PVHG6 consumed aromatics in a similar manner to that of the WT
strain. We used a targeted metabolomic approach to measure the concentration of each individual
aromatic compound in the mixture (0.5 g/L of PHE, GUA, HBA, VAN, and BEN; 2.5 g/L total
aromatics; Figure 2-4B). We observed that both WT and PVHG6 strains consumed BEN and HBA
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Figure 2-4: Growth and consumption of lignin model compounds by WT and adapted
strains. Cells were grown in minimal medium A supplemented with the listed carbon sources and
1 g/L ammonium sulfate as the nitrogen source. (A) Growth of one strain from each aromatic
adaptation experiment and the WT strain in a mixture of lignin model compounds (0.5 g/L each of
GUA, PHE, HBA, VAN, and BEN; 2.5 g/L total aromatics). (B) Aromatic consumption profiles
of WT and PVHG6 strains in the same growth condition as A. Aromatic concentrations were
measured by derivatizing culture supernatants using methyl chloroformate followed by GC-MSFID (see Section 2.5 for details). (C) Growth and consumption of individual aromatic compounds
as a sole carbon source by WT and PVHG6 strains (aromatic concentrations listed above plots).
Aromatic concentrations were estimated using UV absorbance (see Section 2.5 for details). Note
that the y-axis scales for growth and concentration plots vary between carbon sources. For all plots,
points represent the average of three biological replicates and error bars represent one standard
deviation. PHE = phenol, VAN = vanillate, HBA = 4-hydroxybenzoate, GUA = guaiacol, and BEN
= sodium benzoate.
before PHE, GUA, and VAN. Both strains fully consumed BEN and HBA within 24–32 h, while
consumption of PHE, GUA, and VAN began after 24 h for both strains. Within 60 h, all five
compounds were almost fully consumed by the PVHG6 strain, but substantial amounts of PHE
(25%), GUA (83%), and VAN (61%) remained in the WT cultures at 60 h. Overall, PVHG6 had
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a 27% higher total aromatic consumption rate than the WT strain (52 mg/L/h for PVHG6 vs. 41
mg/L/h for the WT strain from 0 to 44 h, P = 0.0024). Additionally, it was found that PVHG6 also
consumed a mixture containing 3 g/L glucose and all five aromatic compounds (0.6 g/L of PHE,
GUA, HBA, VAN, and BEN; 3 g/L total aromatics) as carbon sources, and it completely utilized
all aromatics after 60 h of growth (Figure 2-S7).

2.3.5 Consumption of individual aromatic compounds by PVHG6
To determine whether the improved growth phenotype of PVHG6 on a mixture of lignin
model compounds extended to individual compounds, we measured growth and aromatic
concentrations using six different concentrations of PHE, VAN, HBA, GUA, and BEN as a sole
carbon source (Figures 2-4C, 2-S8–2-S13). Aromatic concentrations were measured using UV
absorbance. From these experiments, we calculated the half maximal inhibitory concentration
(IC50) using OD600 values at 54 h. We only observed a significant increase in the IC50 value of
PVHG6 compared to that of the WT strain when they were grown in PHE (17%, P = 0.003) and
GUA (16%, P = 0.008) (Table 2-S10). The IC50 values of PVHG6 for HBA, VAN, and BEN were
unchanged or slightly decreased (Table 2-S10). When 1 g/L glucose was used as a sole carbon
source, no difference in growth was observed between the WT and PVHG6 strains (Figure 2-S14),
implying that glucose metabolism was not affected by mutations during the long adaptation
process in the absence of glucose.

2.3.6 Transcriptomic analysis of WT and PVHG6 using lignin model
compounds
We had previously observed that changes in gene and pathway expression better explained
improved phenol utilization phenotypes in evolved R. opacus strains, compared to the effect of
genetic changes like SNPs and INDELs in coding regions [86]. Accordingly, we sought to
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determine the potential role of transcriptional differences in the improved tolerance and utilization
of a larger panel of aromatics by the evolved PVHG6 strain. We performed whole cell gene
expression profiling via RNA-Seq on the WT and PVHG6 strains grown in a mixture of all five
lignin model compounds (0.5 g/L of each lignin model compound, 2.5 g/L total aromatics), or in
1 g/L glucose, to identify differentially regulated genes between strains and carbon sources. We
also performed RNA-Seq using 0.5 g/L of each of the five lignin model compounds individually
(PHE, GUA, HBA, VAN, or BEN) to determine compound-specific degradation pathways for
each compound. For the 1 g/L glucose (Glc) and the mixture of five lignin model compounds
(hereafter, “mixture”), we analyzed the transcriptome at both the early and mid-exponential phases
(20 h and 32 h for the mixture; 10 h and 13 h for Glc) since we had observed differential
consumption rates of lignin model compounds in our targeted metabolomic analysis (Figure 24B).
To investigate differences in expression profiles between WT and PVHG6, we first
analyzed all transcriptomic data for both strains using principal component analysis (Figure 2S15). PVHG6 and WT were clearly separated along the first principal component with values
higher than 60 and lower than −50, respectively, while the second principal component generally
separated transcriptional profiles by growth conditions. Permutational ANOVA (PERMANOVA)
indicated that transcriptomic profiles between strains and between growth conditions were
significantly different (P = 0.001, both cases). Based on our genome sequencing data, which was
corroborated by our transcriptomic data (Figure 2-S4), many adapted strains, including PVHG6,
underwent plasmid deletions and plasmid loss. We repeated the principal component analysis with
Plasmid 1 and 2 data removed, and while some growth conditions led to closer visual clustering
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of WT and PVHG6, the strains were still significantly different based on PERMANOVA (P =
0.002; Figure 2-S16).
We then compared the top 30 differentially upregulated genes between both strains grown
in the mixture at both time points (Figure 2-S17).The most upregulated genes in PVHG6 relative
to the WT strain in the mixture at both time points were RS27075 (a hypothetical protein, 41-fold
upregulated) and RS13410 (a type VII secretion-associated protein, 40-fold upregulated),
respectively. Five of the top 30 upregulated genes are annotated as ABC transporters or ABC
transporter associated proteins, suggesting that these ABC transporters might control uptake or
export rates of aromatic compounds. Two genes annotated as acetyl-CoA acetyltransferases
(RS34095 and RS34105) were also in the top 30 list. Both proteins share high positive amino acid
sequence similarity to 3-oxoadipyl-CoA thiolases in R. opacus and R. jostii RHA1 (52–76%
positive identity, Table 2-S11). The final step in the β-ketoadipate pathway is catalyzed by 3oxoadipyl-CoA thiolase, converting 3-oxo-adipyl-CoA into succinyl-CoA and acetyl-CoA.
RS34095 and RS34105 may encode this enzyme, acting as additional gene copies and increasing
the metabolic flux through the β-ketoadipate pathway in PVHG6 when the aromatic mixture is
used.
To identify putative funneling pathway enzymes for each lignin model compound, we
searched for the most strongly upregulated enzymes when both strains were grown in the
individual aromatic compounds and the mixture, compared to the glucose condition (Figure 2-5A).
These selected proteins were then compared to homologous enzymes in a closely-related strain, R.
jostii RHA1, which has a characterized proteome [103] (Table 2-S12). Using this process, we
identified funneling pathway clusters for each lignin model compound: two two-component
phenol

hydroxylases

(RS31555–RS31560 and RS30765–RS30770), a putative vanillate
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demethylase (RS02665–RS02675), a putative 4-hydroxybenzoate monooxygenase (RS31675),
two putative cytochrome P450 clusters upregulated in response to GUA (RS30780–RS30785
[GUA degradation cluster #1] and RS21470–RS21485 [GUA degradation cluster #2]), and a
putative benzoate degradation cluster (RS30790–RS30805). Many of these funneling pathway
enzymes have high sequence similarity to biochemically characterized pathway enzymes in other
Rhodococcus strains, including R. opacus 1CP (Table 2-S12) [104, 105]. Each of these genes or
gene clusters converts lignin model compounds to either catechol (CAT) or protocatechuate (PCA)
for subsequent degradation by the β-ketoadipate pathway (Figure 2-6B). All of these genes were
upregulated in both the individual aromatic condition and the mixture compared to glucose, except
GUA degradation cluster #2 which was upregulated in GUA but not upregulated in the mixture
compared to glucose (Figure 2-5A). This differential expression suggests transcriptional regulation
(i.e., repression) of this funneling pathway in response to the presence of other lignin model
compounds. When the expression of the identified funneling pathways in PVHG6 was compared
to the WT strain in the mixture, most genes at both time points were not differentially expressed
with the exception of the benzoate degradation pathway at the second time point, which was 29–
95-fold downregulated (adjusted p-values < 7 × 10−29). Our metabolomic data (Figure 2-4B)
showed that PVHG6 completely consumed BEN after 24 h (compared to 32 h for WT), which
suggests that the BEN funneling pathway genes were downregulated in PVHG6 in response to
complete consumption of BEN. For other funneling pathways, no genes were more than 2.6-fold
upregulated or downregulated in PVHG6 compared to the WT strain at either time point in the
mixture.
The funneling pathways convert aromatic compounds into two intermediates, CAT or
PCA, for degradation by the β-ketoadipate pathway (Figure 2-6). Previous analyses of
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Rhodococcus strains suggest that VAN and HBA are converted to PCA, while GUA, BEN, and
PHE are converted to CAT [106]. For both WT and PVHG6, we observed upregulation of βketoadipate gene cluster #1 (RS25340–RS25375) compared to the glucose condition for all
aromatic carbon sources (Figure 2-6A). This gene cluster includes genes required to convert both
CAT and PCA into central tricarboxylic acid (TCA) cycle metabolites. In both strains, βketoadipate gene cluster #2 (RS31565–RS31575) was upregulated in PHE and the mixture (up to
5000-fold), but it was upregulated only up to 3-fold in other lignin model compounds compared
to the glucose condition. This observed upregulation could be related to the upstream phenol
hydroxylase (RS31555–RS31560 in the phenol funneling pathway; Figure 2-5A) that is highly
upregulated in PHE compared to the glucose condition. We also observed upregulation of βketoadipate gene cluster #3 (RS30720–RS30745) during growth on all aromatic carbon sources.
In both strains, genes in this cluster, which is typically associated with degradation of CAT
intermediates, were highly upregulated (142–779-fold) by CAT branch compounds (GUA, BEN,
and PHE) relative to the glucose condition, but they were only moderately upregulated (9–93-fold)
by PCA branch compounds (VAN and HBA) relative to the glucose condition. Interestingly, such
a branch-dependence was also observed in regulation of some funneling enzymes (Figure 2-5A).
For example, a phenol hydroxylase (RS30765–RS30770) was also highly upregulated in GUA
(121–477-fold), but minimally upregulated by PCA precursors VAN and HBA (up to 5.9-fold),
compared to the glucose condition in both strains. The putative vanillate demethylase (RS02665–
RS02675) was also upregulated in HBA (114–295-fold), but minimally upregulated by CAT
precursors GUA and BEN (1.4–2.2-fold) in both WT and PVHG6, compared to the glucose
condition. When compared to the WT strain in the mixture, PVHG6 did not show substantial
upregulation of the β-ketoadipate clusters (at most 2.5-fold). This result differs from that of
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previously characterized R. opacus mutants that were adapted using a single compound (PHE) and
that showed large differential upregulation of a number of phenol degradation genes in PHE
compared to the WT strain [86].

Figure 2-5: Activation of lignin model compound funneling pathways in R. opacus. (A) Heat
map of normalized expression counts for upregulated aromatic degradation genes that convert (i.e.
“funnel”) lignin model compounds to the β-ketoadipate pathway during growth on individual
lignin model compounds, a mixture of lignin model compounds, and glucose. Raw counts were
transformed using the variance stabilizing transformation in DESeq2. Darker colors indicate
higher normalized counts (see scale bar). Glc = 1 g/L glucose, PHE = 0.5 g/L phenol, VAN = 0.5
g/L vanillate, HBA = 0.5 g/L 4-hydroxybenzoate, GUA = 0.5 g/L guaiacol, BEN = 0.5 g/L sodium
benzoate, and Multi = 0.5 g/L of PHE, VAN, HBA, GUA, and BEN (2.5 g/L total aromatics). t1
represents cells harvested at early exponential phase (10 h for Glc; 20 h for Multi), while t2
represents cells harvested at mid-exponential phase (13 h for Glc; 32 for Multi). Samples from
individual compound growth conditions were harvested at mid-exponential phase (24 h for WT
PHE, 21 h for PVHG6 PHE, 19 h for WT and PVHG6 GUA, 11 h for WT and PVHG6 HBA, 12
h for WT and PVHG6 BEN, 24 h for WT and PVHG6 VAN). Cells were grown in minimal
medium A. Each square on the heat map represents a biological replicate. (B) Pathway map
showing genes involved in lignin model compound funneling pathways in R. opacus. Gene codes
are from the NCBI reference sequence NZ_CP003949.1. CDCDC = cis-1,2-dihydroxy-cyclohexa3,5-diene-1-carboxylate.
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Figure 2-6: Activation of β-ketoadipate pathway gene clusters by lignin model compounds in
R. opacus. (A) Heat map of normalized gene expression counts for β-ketoadipate pathway gene
clusters during growth on individual lignin model compounds, a mixture of lignin model
compounds, and glucose. Raw counts were transformed using the variance stabilizing
transformation in DESeq2. Darker colors indicate higher normalized counts (see scale bar). Glc =
1 g/L glucose, PHE = 0.5 g/L phenol, VAN = 0.5 g/L vanillate, HBA = 0.5 0.5 g/L 4hydroxybenzoate, GUA = 0.5 g/L guaiacol, BEN = 0.5 g/L sodium benzoate, and Multi = 0.5 g/L
of PHE, VAN, HBA, GUA, and BEN (2.5 g/L total aromatics). t1 represents cells harvested at
early exponential phase (10 h for Glc; 20 h for Multi), while t2 represents cells harvested at midexponential phase (13 h for Glc; 32 h for Multi). Samples from individual compound growth
conditions were harvested at mid-exponential phase (24 h for WT PHE, 21 h for PVHG6 PHE 19
h for WT and PVHG6 GUA, 11 h for WT and PVHG6 HBA, 12 h for WT and PVHG6 BEN, 24
h for WT and PVHG6 VAN). Cells were grown in minimal medium A. Each heat map square
represents a biological replicate. (B) Pathway map showing genes involved in β-ketoadipate
pathway gene clusters in R. opacus. Gene codes are from the NCBI reference sequence
NZ_CP003949.1. (C) Difference between initial OD600 and final OD600 after 24 h of growth for
the RS30730 knockout (∆CAT) strain and the WT strain using different carbon sources. (D)
Difference between initial OD600 and final OD600 after 24 h of growth for the RS25360 knockout
(∆PCA) strain and the WT strain using different carbon sources. For C and D, the WT, ∆CAT, and
∆PCA strains were initially cultured in 2 mL of minimal medium B containing 1 g/L ammonium
sulfate, 4 g/L glucose, and either no aromatic compound, 0.2 g/L PHE, 0.25 g/L GUA, 0.5 g/L
HBA, 0.25 g/L VAN, or 0.5 g/L BEN. Cells were then centrifuged, washed with minimal medium
B containing no carbon source, and re-suspended to an initial OD600 of 0.2 in 10 mL of minimal
medium B containing 1 g/L ammonium sulfate and either 1 g/L glucose, 0.4 g/L PHE, 0.5 g/L
GUA, 1.0 g/L HBA, 0.5 g/L VAN, or 1 g/L BEN as sold carbon sources. Asterisk (*) indicates
that the difference between initial and final OD600 values is less than one standard deviation. Bars
represent the average of three biological replicates and error bars represent one standard deviation.
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To confirm whether the five tested aromatic compounds (PHE, GUA, HBA, VAN, and
BEN) were catabolized via the CAT or PCA branch of the β-ketoadipate pathway, critical genes
from both branches were knocked out, and growth assays were performed. β-ketoadipate gene
cluster #3, which contains the CAT degradation pathway, was knocked out by a disruption of
RS30730 (cis,cis-muconate cycloisomerase; ΔCAT), while β-ketoadipate gene cluster #1, which
contains the PCA degradation pathway, was knocked out by a disruption of RS25360 (3-carboxycis,cis-muconate cycloisomerase; ΔPCA). The knockout of the PCA degradation pathway was
complicated by the fact that other central β-ketoadipate pathway genes required for CAT
degradation are located further downstream in β-ketoadipate gene cluster #1 (Figure 2-6). To
ensure transcription of those downstream genes, a constitutive promoter was integrated into the
genome. The ΔCAT strain was unable to grow using PHE, GUA, and BEN as sole carbon sources,
while the ΔPCA strain was unable to grow using HBA and VAN as sole carbon sources (Figures
2-6C,D). Together, these results confirm that PHE, GUA, and BEN are funneled through the CAT
branch, and HBA and VAN are funneled through the PCA branch of the β-ketoadipate pathway in
R. opacus.
Transporter expression control may be related to aromatic tolerance mechanisms. The
putative shikimate transporter (RS31355), which was significantly upregulated in other phenoladapted R. opacus strains [86], was also upregulated in PHE (281–299-fold) and the mixture (87–
295-fold) for both WT and PVHG6 relative to the glucose condition at both time points. An MFS
transporter (RS33590) was moderately upregulated in response to PCA precursors VAN (137–
193-fold) and HBA (10–15-fold), and the mixture (45–115-fold), but was minimally upregulated
by CAT precursors PHE, GUA, and BEN (1.0–3.7-fold) in WT and PVHG6 at both time points.
Another MFS transporter (RS30810) located adjacent to the BEN degradation cluster was
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upregulated in BEN (1330–1720-fold) and the mixture (958–2620-fold) for both WT and PVHG6
at the first timepoint. At the second time point, the MFS transporter was down-regulated in PVHG6
compared to the WT strain in a similar manner to the BEN degradation cluster (Figure 2-5A). The
MFS transporter RS30810 was also moderately upregulated by CAT precursor GUA (57–62-fold),
but only minimally upregulated by PCA precursors VAN (1.6–7.5-fold) and HBA (1.1–8.7-fold)
in both strains compared to the glucose condition. The branch-dependent upregulation of MFS
transporters RS33590 and RS30810 is similar to what was observed for the β-ketoadipate pathway
(Figure 2-6). Overall, we observed multiple transporters whose expression was responsive to lignin
model compounds.
To explore the role of transporters in aromatic tolerance and utilization, we compared the
growth of three putative transporter knockout mutants (RS31355, RS33590, and RS30810) to that
of the WT strain using different carbon sources (Figure 2-S18). The growth of these knockout
mutants and the WT strain were compared using 0.75 g/L PHE, 1.25 g/L GUA, 1.75 g/L VAN, 2
g/L HBA, 5 g/L BEN, and the combined mixture (2.5 g/L total aromatics) as sole carbon sources.
The putative shikimate transporter (RS31355) knockout mutant had lower cell densities (OD600)
after 48 h than the WT strain using PHE and the mixture as sole carbon sources, which matches
previous reports of RS31355 having a role in PHE transport [86]. The putative vanillate transporter
(RS33590) knockout mutant had lower OD600 values than the WT strain using VAN, PHE, and the
mixture as sole carbon sources. The putative benzoate transporter (RS30810) knockout mutant had
lower OD600 values than the WT strain using BEN, VAN, GUA, PHE, and the mixture as sole
carbon sources (Figure 2-S18). None of the transporter knockout mutants exhibited growth
impairments on HBA (Figure 2-S18). The impaired growth of the putative aromatic transporter
knockout mutants on some compounds suggests transporter specificity and that the influx or efflux
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of aromatic compounds plays an important role in aromatic tolerance and utilization (Figure 2S18).
The consumption of aromatics can lead to the formation of by-products. We observed
upregulation of gene clusters involved in one carbon compound (C1) metabolism during growth
on aromatics (Figure 2-S19). Catabolism of VAN and GUA requires a demethylation step that
releases formaldehyde during conversion to PCA and CAT, respectively [107-109] (Figures 2-5,
2-6). In VAN and GUA growth conditions, we observed the upregulation of a mycothioldependent pathway that converts formaldehyde to CO2, and this pathway is found in Rhodococcus
strains and other actinomycetes [110, 111] (Figure 2-S19). This pathway (RS31920–RS31930)
was upregulated in VAN and GUA (21–105-fold), but expression varied in the mixture from no
significant upregulation to 26-fold upregulation for both strains compared to the glucose control.
Another pathway for formaldehyde degradation is the ribulose mono-phosphate (RuMP) pathway,
which converts formaldehyde and ribulose-5-phosphate to fructose-6-phosphate for consumption
via the pentose phosphate pathway [112]. The RuMP pathway (RS21455–RS21460) was
upregulated in VAN and GUA (450–2600-fold) compared to the glucose condition in both the WT
strain and PVHG6. In the mixture, the RuMP pathway was upregulated in the WT strain (23–135fold) and PVHG6 (3–172-fold) relative to the glucose condition. Genes in the RuMP pathway are
also located near the pentose phosphate pathway operon, which was upregulated in a similar
pattern to the RuMP pathway (Figure 2-S19). Together, these results suggest that R. opacus has
multiple formaldehyde degradation pathways which are activated only when they are necessary
(e.g., when VAN or GUA is catabolized, generating the toxic by-product).
To better understand the effect of mutations on the improved growth phenotype of PVHG6,
we compared the expression of genes with mutations found in PVHG6 as well as genes with
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mutations found in multiple adaptation conditions (Figures 2-S20, 2-S21). Of the genes with
mutations in PVHG6, SOD (RS01890), non-ribosomal peptide synthetase (RS13070), and
cytochrome ubiquinol oxidase (RS14825) were highly expressed (> 500 normalized counts) in
both the WT and PVHG6 strains across all tested growth conditions, including the high glucose
condition (Figure 2-S20). For genes with mutations found across multiple adaptation conditions
(Figure 2-3B, Table 2-S5), SOD (RS01890), cytochrome ubiquinol oxidase (RS14825),
phosphoenolpyruvate carboxykinase (RS08140), and fructose bisphosphate aldolase (RS10095)
were highly expressed (> 500 normalized counts, Figure 2-S21). These results suggest that
mutations could play a role in phenotypic differences between WT and PVHG6 strains, possibly
by changing specific enzyme activities (e.g., SOD, Figure 2-S5), instead of changing expression
levels of highly expressed genes (Figures 2-S20, 2-S21).

2.3.7 Lipid production using lignin model compounds
To determine the effect of the adaptation on the ability of R. opacus to convert lignin model
compounds into a bioproduct (e.g., lipids), we compared total lipid production between WT and
PVHG6 grown in 2.5 g/L of lignin model compounds (0.5 g/L each of PHE, GUA, HBA, VAN,
and BEN) in minimal medium A in a low nitrogen condition (Figure 2-7). PVHG6 reached a 50%
higher cell density (OD600) than the WT strain after 72 h, and it accumulated 44% of its cell dry
weight as lipids, compared to only 26% by WT (Figure 2-7). After 72 h, the adapted strain reached
a lipid titer of 0.13 g/L using lignin model compounds as a sole carbon source, which is a 225%
increase compared to the WT strain (Figure 2-7B). These results suggest that adaptive evolution
can lead to significant improvements in lipid production by increasing lignin model compound
tolerance and consumption.
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Figure 2-7: Conversion of lignin model compounds to lipids. (A) Growth of WT and PVHG6
strains in low nitrogen conditions using minimal medium A with 0.5 g/L of PHE, VAN, HBA,
GUA, and BEN (2.5 g/L total aromatics) as carbon sources and 0.125 g/L ammonium sulfate as
the nitrogen source. (B) Lipid content and lipid titer of WT and PVHG6 strains after 72 h of growth
in the same growth conditions as A. For all plots, points and bars represent the average of three
biological replicates and error bars represent one standard deviation. Asterisk (*) indicates that the
difference between WT and PVHG6 values is statistically significant (P < 0.05, one mean, twotailed Student’s t-test).

2.4 Discussion
Microbial tolerance and consumption of aromatic mixtures is a complex, understudied
phenotype that involves numerous interactions between many genes and pathways. An improved
understanding of this complex phenotype and its underlying mechanisms is critical for efficient
lignin valorization. In this work, we investigated lignin model compound tolerance and utilization
by combining adaptive evolution and multi-omic approaches. We demonstrated that R. opacus can
be adaptively evolved to improve consumption of aromatic mixtures, and we identified shared
mutations in adapted strains from multiple adaptation experiments that could affect aromatic
tolerance and utilization. We observed that the adapted strain PVHG6 had higher aromatic
consumption rates than the WT strain in a mixture of lignin model compounds, and we identified
five upregulated funneling pathways and two by-product detoxification pathways that were
responsive to specific lignin model compounds. Furthermore, our results demonstrate that
enzymatic activities which affect levels of intracellular molecular oxygen and superoxide radicals
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likely play an important role in aromatic tolerance and utilization. Overall, this work highlights
the value of combining adaptive evolution with a multi-omic approach to provide insights into
microbial aromatic tolerance and utilization, to create improved strains for aromatic mixture
consumption, and to identify novel targets for engineering R. opacus strains toward lignin
valorization.
The ability of R. opacus to successfully adapt to a mixture of lignin model compounds in
a relatively small number of generations could be related to its relatively high mutation rate. Across
all adaptation experiments, we observed an average of 32 mutations after ~ 270–420 generations
(~ 4 generations per subculture) (Table 2-S1), which is at least an order of magnitude higher than
rates of occurrence observed in Escherichia coli under stress conditions [113]. Even in the high
glucose condition, the average mutation occurrence was 19 mutations after ~ 290 generations in
R. opacus. This high occurrence of mutations was not the result of any mutations in the DNA
recombination and repair system, which are often found in hypermutator strains [114-116].
Notably, a large portion of SNPs observed in R. opacus were synonymous SNPs (Table 2-S2).
While synonymous SNPs could potentially affect gene expression rates, protein folding, and thus
protein functions [117], most synonymous SNPs in both the glucose and aromatic adaptation
conditions were located in the same region of Plasmid 1, suggesting that these mutations are not
related specifically to aromatic tolerance and utilization.
The most frequently mutated genes in R. opacus were related to redox reactions (Figure 23B). One such example was SOD, a highly conserved enzyme that protects cells from superoxide
radicals (O2-) by converting them into molecular oxygen (O2) or hydrogen peroxide (H2O2) [118].
We also observed multiple mutations affecting cytochrome ubiquinol oxidase in all phenolic
compound adapted strains, but not in the high glucose or BEN adapted strains. This gene was also
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mutated in a previous R. opacus adaptation experiment using phenol as a sole carbon source [86].
Cytochrome ubiquinol oxidase catalyzes the terminal step in one of the electron transport chains
present in Rhodococcus strains, which reduces O2 to H2O [119]. The exact mechanistic
contribution of these two mutated enzymes to the evolved aromatic phenotypes is not fully
understood, but the known utilization of superoxide radicals and O2 during aromatic consumption
may provide some insights. Super-oxide radicals are generated from O2 by aromatic degradation
enzymes, including monooxygenase funneling enzymes (e.g., HBA mono-oxygenase) [102] and
ring splitting dioxygenases (e.g., catechol 1,2-dioxygenase) [101], to facilitate aromatic
catabolism. Our observation that PVHG6 had a 56% decreased SOD activity relative to the WT
strain suggests a greater availability of superoxide radicals for aromatic degradation enzymes in
PVHG6 than the WT strain.
By performing transcriptomic analyses on strains grown on single compounds, we were
able to identify distinct funneling pathways for five lignin model compounds (Figure 2-5) and two
aromatic by-product detoxification pathways (Figure 2-S19). The responses of funneling pathways
to individual compounds and the mixture (Figure 2-5A), together with a distinct consumption
pattern of lignin model compounds in the mixture (Figure 2-4B), suggest that R. opacus can
differentially and specifically regulate aromatic utilization pathways in response to specific
compounds. Carbon catabolite repression in Rhodococcus strains has been reported between
aromatic compounds such as benzoate and phthalate [120] and 4-methoxybenzoate and 2ethoxyphenol [121]. Relatedly, we observed differential upregulation of guaiacol degradation
cluster #2 between the GUA growth condition and the mixture in both WT and PVHG6 strains
(Figure 2-5A), suggesting that the presence of other aromatic compounds may delay guaiacol
consumption (Figure 2-4B) by reducing the expression level of guaiacol degradation cluster #2.
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Additionally, two pathways for a by-product of VAN and GUA catabolism, formaldehyde, in
addition to the gluconeogenesis and pentose phosphate pathway genes that produce required
enzymatic substrates, were all upregulated in both strains in the VAN, GUA, and mixture growth
conditions (Figure 2-S19). Several transporter genes were also upregulated, and gene knockout
experiments demonstrated their importance for aromatic utilization or tolerance, as suggested
previously [86]. Together, these results show that R. opacus encodes a complex catabolic network
for aromatic utilization, which includes a number of aromatic transporters and metabolic pathways
that are regulated in a compound-specific manner.
In our previous report, we performed adaptive evolution using phenol as a sole carbon
source [86]. Because lignin depolymerization generates heterogeneous aromatic mixtures,
understanding tolerance and utilization mechanisms for a greater diversity of aromatic compounds
and mixtures is necessary for lignin valorization. Accordingly, our current work tackles a
substantially expanded set of adaptive evolution experiments on multiple lignin model compounds
(including phenol) and their mixtures. From this large number of evolved trajectories, we chose
six adaptive evolution experiments which represented both substrate diversity and mixture
complexity and performed comparative multi-omic analyses of selected mutant strains that were
grown in these diverse aromatic carbon sources. Our comprehensive, multi-omic analyses allowed
for elucidation of improved aromatic catabolism in evolved R. opacus strains as well as
identification of multiple compound-specific pathways, facilitating future lignin valorization
efforts.

2.5 Materials and Methods
2.5.1 Chemicals and strains
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Chemicals were purchased from Sigma Aldrich (St. Louis, MO) unless otherwise
indicated, and Rhodococcus opacus PD630 (DSMZ 44193) was used as the ancestral strain (WT)
for comparison to all mutated strains. For all growth experiments (unless otherwise indicated),
cells were grown at 30 °C and 250 rpm in one of two defined minimal salts media (A or B; medium
composition as previously described [106]). Culture media were filter-sterilized using a 0.22 μm
filter, and pH was adjusted to 7.0 using 6 M HCl or 2 M NaOH. Carbon and nitrogen sources were
added as sterile-filtered stock solutions. R. opacus strains were maintained on tryptic soy broth
(TSB) plates supplemented with 1.5% agar.

2.5.2 Adaptive evolution and growth assays of adapted strains
R. opacus was serially passaged on combinations of protocatechuate (PCA), guaiacol
(GUA), phenol (PHE), 4-hydroxybenzoate (HBA), and vanillate (VAN) as carbon sources, and it
was also passaged on each compound individually (Figure 2-1). R. opacus was also adapted on
sodium benzoate (BEN) and high concentrations of glucose individually as sole carbon sources.
Minimal medium A was used for adaptation experiments. To start adaptation experiments, a single
colony of the ancestral strain from a TSB agar plate was grown at 30 °C in 2 mL of minimal
medium A supplemented with 0.3 g/L PHE for 24–48 h, followed by a subculture using an initial
OD600 of 0.05 in 10 mL of the same media for 24 h. Next, cells were centrifuged at 3000 g for 10
min and resuspended in minimal medium A without carbon or nitrogen sources, and adaptation
experiments were performed at a 10 mL culture volume in a 50 mL glass culture tube with the
corresponding carbon source(s) (Table 2-S1) and 1 g/L ammonium sulfate as the nitrogen source.
For passaging, cultures were started at an initial cell density (OD600) of 0.03. After ~ 30 passages,
the initial cell density was increased to 0.05 for all adaptation experiments. Cells were passaged
after reaching mid-exponential phase (OD600> 0.3), and cells from each adaptation experiment at
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each passage were stored at −80 °C in 15% glycerol. At each passage, the total aromatic
concentration was increased by 1–5% until we did not observe growth after three days. If cells did
not grow after three days, the culture was restarted from the previous −80 °C frozen stock, and the
overall aromatic concentration was decreased until cell growth could be recovered. Once growth
was recovered, the concentration was held constant for multiple passages before increasing
concentrations in following passages. Adaptation experiments were stopped when we observed no
growth after restarting adaptations from frozen stocks or adaptations reached > 100 passages. See
Table 2-S1for details on adaptation experiments.
To isolate colonies, adapted cultures were streaked on minimal medium plates
supplemented with 1.5% agar, 1 g/L ammonium sulfate, and respective carbon sources from the
adaptation experiment (concentrations as indicated in Table 2-S13). Six colonies were picked and
grown at 30 °C in a 5 mL culture volume in a 50 mL glass tube with minimal medium A
supplemented with 5 g/L glucose and 1 g/L ammonium sulfate for 36 h before storage at −80 °C
in 15% glycerol. To compare the phenotype of the isolated colonies to that of the WT strain using
their adaptation carbon sources (Figure 2-2), frozen stocks of each isolated strain were streaked on
TSB plates and a single colony was grown in 2 mL of minimal medium A supplemented with
lignin model compounds from their adaptation condition (concentrations as indicated in Table 2S13) for 24–48 h, and then subcultured using an initial OD600 of 0.05 in 10 mL of lignin model
compounds from their adaptation condition (concentrations as indicated in Table 2-S14) for 24 h.
Next, cells were centrifuged at 3000 g for 10 min and resuspended in minimal medium A without
carbon or nitrogen sources, and experiments were performed at 30 °C with a 10 mL culture volume
in a 50 mL glass culture tube with adaptation carbon source(s) (concentrations as indicated in
Figure 2-2) and 1 g/L ammonium sulfate as the nitrogen source. Growth was monitored using
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absorbance at 600 nm (Abs600). Absorbance measurements were made with black 96 well plates
(Greiner BioOne) using a TECAN Infinite M200 Pro plate reader. OD600 values were obtained by
converting the Abs600 of 200μL of cell culture to OD600 using an experimentally determined
correlation curve (OD600=1.975 * [Abs600−0.04], R2= 1.00). Specific growth rates were calculated
by fitting at least four converted OD600 values in the log phase.

2.5.3 R. opacus cultures for targeted metabolomics and transcriptomics
For phenotyping of adapted strains outside of adaptation conditions (Figures 2-4A, C),
targeted metabolomics experiments (Figure 2-4B), and transcriptomic experiments (Figures 2-5,
2-6), cultures were started as follows. −80 °C frozen stocks of isolated colonies were streaked onto
TSB agar plates and grown at 30 °C for three days. Using a loopful of cells from a TSB plate, seed
cultures were grown at 30 °C in 2 mL of minimal medium A or B supplemented with lignin model
compounds (0.2 g/L of BEN, GUA, PHE, HBA, and VAN, 1 g/L total aromatics) as carbon sources
for 24 h, and then subcultured in 10 mL of the same media for 24 h with an initial cell density
(OD600) of 0.05. Next, cells were centrifuged at 3000 g for 10 min and resuspended in minimal
medium A or B without carbon or nitrogen sources, and experiments were performed at 30 °C with
a 10 mL culture volume in a 50 mL glass culture tube with respective carbon source(s) (see below
for concentrations) and 1 g/L ammonium sulfate as the nitrogen source. For phenotyping of strains
outside of adaptation conditions, 0.5 g/L of BEN, GUA, PHE, HBA, and VAN (2.5 g/L total
aromatics), 0.6 g/L of BEN, GUA, PHE, HBA, and VAN (3.0 g/L total aromatics), or a
combination of aromatics and glucose were used as carbon sources (at concentrations as indicated
in figure captions). For targeted metabolomics experiments, 0.5 g/L of BEN, GUA, PHE, HBA,
and VAN (2.5 g/L total aromatics) were used as carbon sources. For growth assays using individual
compounds as sole carbon sources, six different concentrations of BEN (5, 6, 7, 8, 9, and 10 g/L),
36

GUA (1.25, 1.5, 1.75, 2, 2.25, and 2.5 g/L), PHE (0.75, 1, 1.25, 1.5, 1.75, and 2 g/L), HBA (2,
2.25, 2.5, 2.75, 3, and 3.25 g/L), and VAN (1.25, 1.5, 1.75, 2, 2.25, and 2.5 g/L) were used. For
transcriptomic experiments, seven different growth media were used: 0.5 g/L of BEN, 0.5 g/L of
GUA, 0.5 g/L of PHE, 0.5 g/L of HBA, 0.5 g/L of VAN, and 1 g/L of glucose; and 0.5 g/L of
BEN, GUA, PHE, HBA, and VAN (2.5 g/L total aromatics). Carbon sources are listed in the
respective figure or table. Growth was monitored using Abs600 as described previously.

2.5.4 DNA extraction and sequencing library preparation
DNA was extracted using a standard bead-beating, phenol-chloroform extraction
methodology [86], and DNA concentrations were quantified using a Quant-iT PicoGreen dsDNA
Assay Kit (Thermo Fisher Scientific). The DNA was prepared for sequencing using a Nextera
Tagmentation Kit (Illumina) [122, 123]. Samples were barcoded using a KAPA HiFi HotStart
ReadyMix PCR Kit (KAPA Biosystems). The resulting PCR products were cleaned using
Agencourt AMPure XP Beads (Agencourt Bioscience Corporation) and stored at −20 °C until use.
For sequencing, samples were pooled together in equimolar ratios and diluted to a final DNA
concentration of 10 nM using nuclease free water.

2.5.5 Genome sequencing and SNP analysis
For whole genome sequencing (Figure 2-3), 20μL of the pooled barcoded DNA samples
were submitted for sequencing at the Center for Genome Sciences & Systems Biology,
Washington University in St. Louis School of Medicine. Samples were paired-end sequenced
using an Illumina Hi-Seq 2500 System. Raw Illumina paired-end reads were demultiplexed using
barcodes and quality trimmed using Trimmomatic [124]. Trimmed reads were mapped to the
Chinese Academy of Science reference genome of R. opacus (ASM59954v1) [95] with the
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updated RefSeq annotation (GCF_000599545.1) using Bowtie2 [125]. The resulting SAM files
were converted to BAM files and indexed using SAMtools [126]. SNPs and INDELs were called
using Pilon [127], and SNPs also appearing in the WT strain were removed using an in-house
Python script before quality filtering using GATK [128]. Trimmed reads were also de novo
assembled using SPAdes [129], and the resulting genome assembly was used to confirm the
presence or absence of SNPs using BLAST+ [130]. Additionally, de novo confirmed SNPs were
compared to another reference genome from the Broad Institute (ASM23433v1) [131] to filter out
SNPs that were identical to the Broad Institute reference genome. Gene Ontologies [98] were
inferred with Blast2GO [132] by finding the top 20 most similar protein sequences in the NCBI
and UniProt Knowledgebase databases for every protein in the R. opacus genome using BLAST+
and InterProScan [133].

2.5.6 RNA extraction and rRNA depletion
RNA was extracted using a ZR Fungal/Bacterial RNA MiniPrep Kit (Zymo Research) and
treated with TURBO DNase I (Ambion) for 30 min at 37 °C to remove DNA contamination.
DNase-treated RNA was then cleaned using an RNA Clean & Concentrator Kit (Zymo Research).
Samples were checked for DNA contamination by PCR amplification using primers specific to
intergenic regions of the genome. Samples that were positive for DNA contamination were retreated with TURBO DNase I and cleaned until no DNA was detected by PCR amplification. Next,
RNA was quantified using a NanoVue Plus™ Spectrophotometer (Biochrom), and ribosomal
RNA (rRNA) was depleted from total RNA using a Bacterial Ribo-Zero rRNA Removal Kit
(Illumina). The resulting mRNA was converted to cDNA and barcoded using a reverse
transcription protocol described previously [86]. cDNA samples were pooled together in
equimolar ratios and diluted to a final cDNA concentration of 10 nM using nuclease free water.
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2.5.7 Transcriptomic analysis
For transcriptomic analysis of WT and PVHG6 strains (Figures 2-5, 2-6), 20 μL of the
pooled barcoded cDNA samples were submitted for sequencing at the Center for Genome Sciences
& Systems Biology, Washington University in St. Louis School of Medicine. Samples were singleend sequenced using an Illumina Hi-Seq 2500 System. Raw single-end reads were demultiplexed,
trimmed, and mapped in the same manner as the SNP analysis described previously. After indexing
mapped reads, expression counts were calculated for each gene using featureCounts [134], and
downstream differential gene expression analysis was performed using DESeq2 [135].

2.5.8 Aromatic consumption profiling
For cultures using a single carbon source, the concentration of each lignin model compound
was estimated by comparing UV absorbance values to a standard curve for each lignin model
compound (Figures 2-4C, 2-S22). 200μL of each cell culture was centrifuged at 16,000 g for 5
min, and the UV absorbance value of a 100-fold dilution of culture supernatant was measured in a
UV transparent 96 well plate (ThermoScientific) using a TECAN Infinite M200 Pro plate reader,
or in a quartz cuvette using a Nanodrop 2000 (Thermo Scientific). For cultures using the aromatic
mixture (Figure 2-4B), aromatics in the culture supernatant were derivatized using methyl
chloroformate [136] and quantified using a custom GC-MS-FID system (gas chromatographymass spectrometry-flame ionization detector). Briefly, the culture supernatant was centrifuged at
16,000 g for 5 min, and 200 μL of the culture supernatant was mixed with 40 μL of 5.0% (w/w)
sodium hydroxide solution, 200 μL of methanol, and 50 μL of pyridine. Methylchloroformate (50
μL) was added to the mixture in two 25 μL aliquots. Next, 400 μL of chloroform containing a
decane internal standard was added to the sample, followed by the addition of 400 μL of 50 mM
sodium bicarbonate solution to induce phase separation of the aqueous and organic layers. Samples
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were vortexed between each step to ensure complete mixing. After phase separation, the organic
phase was transferred to a GC vial with a 350 μL glass insert (Agilent), and samples were analyzed
using an Agilent 7890A GC coupled to both an Agilent 5975C mass spectrometer containing a
triple-axis detector and an Agilent G3461A FID detector with a methanizer (Activated Research
Company). The Agilent 7890A GC was equipped with a Restek fused silica RTX-50 capillary
column (30 m by 0.25 mm, 0.5 μm film thickness), and helium was used as the carrier gas. 1 μL
of the organic phase was injected with a splitting ratio of 10:1 using the autosampler. For GC runs,
the inlet was maintained at 250 °C, and the oven was held for 2 min at 40 °C, heated to 300 °C
using a 5 °C/min ramp, and held at 300 °C for 5 min. All data was exported and analyzed using
the Agilent ChemStation Software, and peak intensities were normalized to the decane internal
standard. Lignin model compounds were identified based on retention time and mass spectral
database searches using the Palisade Complete Mass Spectral Database (600 K edition, Palisade
Mass Spectrometry, Ithaca, NY), and concentrations were determined using an external standard
curve for each lignin model compound.

2.5.9 Lipid assay
For lipid production assays (Figure 2-7), growth experiments were performed in the same
way as metabolomic and transcriptomic experiments with the following modification: the culture
volume was 50 mL in a 250 mL baffled flask, the carbon sources for the experiment were 0.5 g/L
of BEN, GUA, PHE, HBA, and VAN (2.5 g/L total aromatics), and the nitrogen source for the
experiment was 0.125 g/L ammonium sulfate. Lipid was measured gravimetrically using a
modified Folch lipid extraction [137]. To measure biomass content, 10 mL of cell culture was
centrifuged at 4600 g for 15 min, washed twice with distilled water, dried at 60 °C for two days,
and weighed to determine the dry cell weight. For lipid extractions, 30 mL of cell culture was
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centrifuged at 4600 g for 15 min, washed twice with distilled water, and resuspended in 4 mL of a
chloroform/methanol solution (2:1). Next, the solution was sonicated at 20% amplitude using the
program: 1 s on and 1 s off for 5 min. The solution was partitioned into aqueous and organic phases
using 0.2 volumes of 0.9% NaCl solution. The organic phase was separated from the aqueous
phase, dried under vacuum, and weighed to determine the total lipid amount.

2.5.10 Generation of R. opacus knockout mutants
Knockout mutants were generated via homologous recombination in the wild type R.
opacus strain as described previously [138]. Briefly, a helper plasmid expressing a pair of
recombinases (pDD120) was introduced via electroporation into WT R. opacus. Electrocompetent
cells were made from this strain as previously described [106]. An integration vector containing
an antibiotic resistance marker and DNA regions homologous to each target gene (~ 500 bp per
homologous arm) was then introduced into the strain harboring the recombinase helper plasmid
by electroporation [138]. Successful recombination was confirmed by colony PCR. See Table 2S15 for plasmids utilized for knockouts and Table 2-S16 for all strains generated. Plasmid DNA
was isolated from Escherichia coli DH10B for electroporation into R. opacus using the Zyppy
Plasmid Miniprep Kit (Zymo).

2.5.10 Data Availability
Genomic and transcriptomic sequences have been deposited with the Sequence Read
Archive (SRA) of the National Center for Biotechnology Information (NCBI) under accession
number SRP131196.
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2.6 Supplemental Figures
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Figure 2-S1: Cell density comparison between WT and adapted strains. Values are based on
the data in Figure 2-2 and reported as improvement of final cell density (OD600) in the adapted
strain compared to OD600 of the WT strain. % improvement = (AdaptedOD600 – WTOD600) / WTOD600
x 100%, where AdaptedOD600 and WTOD600 is the OD600 of the adapted and WT strains,
respectively, after 43 hours of growth. Cells were grown in a minimal salts medium supplemented
with the listed carbon sources as the sole carbon sources and 1 g/L ammonium sulfate as the
nitrogen source. (A) The phenol adapted strains (P1-6). (B) The phenol and vanillate adapted
strains (PV1-6). (C) The phenol, vanillate, and 4-hydroxybenzoate adapted strains (PVH1-6). (D)
The phenol, vanillate, 4-hydroxybenzoate, and guaiacol adapted strains (PVHG1-6). (E) The
sodium benzoate adapted strains (B1-6). (F) The high glucose adapted strains (Glc1-6). Bars
represent the average of three biological replicates and error bars represent one standard deviation.
PHE = phenol, VAN = vanillate, HBA = 4-hydroxybenzoate, GUA = guaiacol, and BEN = sodium
benzoate.
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Figure 2-S2: Aromatic concentrations in culture supernatants after 43 hours for WT and
aromatic compound adapted strains. A. The PHE and VAN adapted strain PV1 compared to the
WT strain using 1.2 g/L PHE and 1.2 g/L VAN. B. The PHE, VAN, and HBA adapted strain PVH5
compared to the WT strain using 0.5 g/L PHE, 1 g/L HBA, and 1 g/L VAN. C. The PHE, VAN,
HBA, and GUA adapted strain PVHG6 compared to the WT strain using 0.4 g/L GUA, 0.4 g/L
PHE, 0.7 g/L HBA, and 0.7 g/L VAN. D. The sodium benzoate adapted strain B2 compared to the
WT strain using 9.4 g/L BEN. E. The phenol adapted strain P1 compared to the WT strain using
1.1 g/L PHE. Aromatic concentrations were measured by derivatizing culture supernatants using
methyl chloroformate followed by GC-MS-FID (see Materials and Methods for details). Cells
were grown in a minimal medium A supplemented with the listed carbon sources (same as Fig. 2)
as the sole carbon sources and 1 g/L ammonium sulfate as the nitrogen source. Bars represent the
average of three biological replicates and error bars represent one standard deviation. The dotted
lines indicate the initial aromatic concentration. PHE = phenol, VAN = vanillate, HBA = 4hydroxybenzoate, GUA = guaiacol, and BEN = sodium benzoate.
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Figure 2-S3: Genes with non-synonymous and intergenic SNPs in adapted strains separated
by adaptation conditions. Some genes have multiple mutations, so each row represents a specific
mutation. Strain names indicate the adaptation condition from which the strain originates: P =
phenol; PV = phenol and vanillate; PVH = phenol, vanillate, and 4-hydroxybenzoate; PVHG =
phenol, vanillate, 4-hydroxybenzoate, and guaiacol; B = sodium benzoate; Glc = glucose.
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Figure 2-S4: Average sequencing depth for all sequenced strains (35 mutants and WT) and
normalized counts in all transcriptomic samples (PVHG6 and WT). A. The average
sequencing depth per base pair in the chromosome or plasmids. Average sequencing depth values
were calculated by summing the total sequencing depth of all the individual base pairs on the
chromosome or plasmid and dividing by the number of base pairs on the respective chromosome
or plasmid. Sequencing depths were then normalized by the average depth of the chromosome for
each strain. B. Average normalized counts were calculated by summing the total number of reads
per kilobase of transcript per million mapped reads (RPKM) for each gene on the chromosome or
plasmid and dividing by the number of genes on the respective chromosome or plasmid. The
average RPKM values were then normalized by the average RPKM value of the chromosome for
each strain. Glc = 1 g/L glucose, P = 0.5 g/L phenol, V = 0.5 g/L vanillate, H = 0.5 g/L 4hydroxbenzoate, G = 0.5 g/L guaiacol, B = 0.5 g/L sodium benzoate, and Mixture = 0.5 g/L of
phenol, vanillate, 4-hydroxybenzoate, guaiacol, and sodium benzoate (2.5 g/L total aromatics). For
Glc and Mixture, “1” represents cells harvested at early exponential phase (10 hours for Glc; 20
hours for Mixture), while “2” represents cells harvested at mid-exponential phase (13 hours for
Glc; 32 hours for Mixture). Samples from individual compound growth conditions were harvested
at mid-exponential phase (24 hours for WT P, 21 hours for PVHG6 P, 19 hours for WT and
PVHG6 G, 11 hours for WT and PVHG6 H, 12 hours for WT and PVHG6 B, and 24 hours for
WT and PVHG6 V). All transcriptomics experiments were performed in minimal medium A. For
B, numerical values represent the average of three biological replicates.
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Figure 2-S5: Comparison of superoxide dismutase (SOD) activity from WT and PVHG6 cell
lysates. Measured relative SOD activity from WT and PVHG6 cell lysates. Asterisk indicates
significant difference from WT SOD activity (P = 0.002, one mean, two-tailed Student’s t-test).
Cells were initially cultured in 2 mL of minimal medium A supplemented with 0.2 g/L of sodium
benzoate, phenol, guaiacol, 4-hydroxybenzoate, and vanillate (1 g/L total aromatics) and 1 g/L
ammonium sulfate for 24 hours, and then subcultured in 10 mL of minimal medium A
supplemented with 0.2 g/L of sodium benzoate, phenol, guaiacol, 4-hydroxybenzoate, and
vanillate (1 g/L total aromatics) and 1 g/L ammonium sulfate for 24 hours to an OD600 of ~0.5.
Cells were grown in 100 mL of minimal medium A supplemented with 1 g/L glucose and 1 g/L
ammonium sulfate to mid-exponential phase (OD600 = 0.44-0.49 for both strains; three replicates).
Cultures (the same number of cells equivalent to OD600 = 0.44 for both strains by adjusting
volumes for harvesting) were centrifuged at 1000g and 4 °C for 15 minutes, resuspended in 300
µL of EMD Millipore BugBuster Protein Extraction Reagent, and incubated at room temperature
for 30 minutes. Next, the lysed cells were centrifuged at 16,000g and 4 °C for 10 minutes, and a
ten-fold dilution of supernatant was used for testing. SOD activity was measured using the
Invitrogen Superoxide Dismutase Colorimetric Activity Kit. SOD activity was compared to a
standard curve generated using bovine erythrocyte superoxide dismutase in the Kit. Bars represent
the average of three biological replicates and error bars represent one standard deviation.
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Figure 2-S6: Growth of WT and adapted strains in a mixture of lignin model compounds.
Growth of strains isolated from adapted cultures in 0.6 g/L of sodium benzoate, phenol, guaiacol,
4-hydroxybenzoate, and vanillate (3 g/L total aromatics) using minimal medium A. Cells were
initially cultured in 2 mL of minimal medium A supplemented with 0.2 g/L of sodium benzoate,
phenol, guaiacol, 4-hydroxybenzoate, and vanillate (1 g/L total aromatics) and 1 g/L ammonium
sulfate for 24 hours, and then subcultured in 10 mL of minimal medium A supplemented with 0.2
g/L of sodium benzoate, phenol, guaiacol, 4-hydroxybenzoate, and vanillate (1 g/L total aromatics)
and 1 g/L ammonium sulfate for 24 hours to an OD600 of ~0.5. For all data shown, cultures were
grown in 10 mL of minimal medium A supplemented with 1 g/L ammonium sulfate as the nitrogen
source with an initial OD600 of 0.05. Points represent the average of three biological replicates and
error bars represent one standard deviation.

47

Figure 2-S7: Growth of PVHG6 using glucose, lignin model compounds, and a mixture of
glucose and lignin model compounds as carbon sources. Growth of PVHG6 in 0.6 g/L each of
sodium benzoate, phenol, guaiacol, 4-hydroxybenzoate, and vanillate (3 g/L total aromatics), 3 g/L
glucose (glc), or both glucose and aromatics as carbon sources. Cells were initially cultured in 2
mL of minimal medium B supplemented with 0.2 g/L each of sodium benzoate, phenol, guaiacol,
4-hydroxybenzoate, and vanillate (1 g/L total aromatics) and 1 g/L ammonium sulfate for 24 hours,
and then subcultured in 10 mL of minimal medium B supplemented with 0.2 g/L each of sodium
benzoate, phenol, guaiacol, 4-hydroxybenzoate, and vanillate (1 g/L total aromatics) and 1 g/L
ammonium sulfate for 24 hours to an OD600 of ~0.5. For all data shown, cultures were grown in
10 mL of minimal medium B supplemented with 1 g/L ammonium sulfate as the nitrogen source
with an initial OD600 of 0.1. Points represent the average of three biological replicates and error
bars represent one standard deviation. Asterisk (*) indicates a significantly higher OD600 value (P
< 0.05, one mean, two-tailed Student’s t-test) for the 3 g/L glucose + 3 g/L aromatics condition
than both the 3 g/L glucose and 3 g/L aromatics conditions. Analysis of derivatized culture
supernatants by GC-MS-FID at the 60 hour time point showed that all aromatics were consumed
for both the 3 g/L aromatics and the 3 g/L glucose + 3 g/L aromatics conditions.
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Figure 2-S8: Growth comparison of PVHG6 and WT strains using individual lignin model
compounds. Growth comparison of PVHG6 and WT strains in different concentrations of
individual lignin model compounds. The individual compound used for growth is listed next to the
y-axis, and the strain is listed above each column. Cells were initially cultured in 2 mL of minimal
medium A supplemented with 0.2 g/L of sodium benzoate, phenol, guaiacol, 4-hydroxybenzoate,
and vanillate (1 g/L total aromatics) and 1 g/L ammonium sulfate for 24 hours, and then
subcultured in 10 mL of minimal medium A supplemented with 0.2 g/L of sodium benzoate,
phenol, guaiacol, 4-hydroxybenzoate, and vanillate (1 g/L total aromatics) and 1 g/L ammonium
sulfate for 24 hours to an OD600 of ~0.5. For all data shown, cultures were grown in 10 mL of
minimal medium A supplemented with 1 g/L ammonium sulfate as the nitrogen source with an
initial OD600 of 0.05. Points represent the average of three biological replicates and error bars
represent one standard deviation. PHE = phenol, GUA = guaiacol, VAN = vanillate, HBA = 4hydroxybenzoate, BEN = sodium benzoate.
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Figure 2-S9: Phenol (PHE) consumption profiles of WT and PVHG6 strains grown in
different PHE concentrations. A. 0.75 g/L. B. 1 g/L. C. 1.25 g/L. D. 1.5 g/L. E. 1.75 g/L. F. 2
g/L. Points represent the average of three biological replicates and error bars represent one standard
deviation. Phenol concentration was measured in culture supernatants using absorbance at 270 nm.
See Fig. 2-S8 for growth conditions and profiles.
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Figure 2-S10: Guaiacol (GUA) consumption profiles of WT and PVHG6 strains grown in
different GUA concentrations. A. 1.25 g/L. B. 1.5 g/L. C. 1.75 g/L. D. 2 g/L. E. 2.25 g/L. F. 2.5
g/L. Points represent the average of three biological replicates and error bars represent one standard
deviation. Guaiacol concentration was measured in culture supernatants using absorbance at 274
nm. See Fig. 2-S8 for growth conditions and profiles.
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Figure 2-S11: Sodium benzoate (BEN) consumption profiles of WT and PVHG6 strains
grown in different BEN concentrations. A. 5 g/L. B. 6 g/L. C. 7 g/L. D. 8 g/L. E. 9 g/L. F. 10
g/L BEN. Points represent the average of three biological replicates and error bars represent one
standard deviation. Sodium benzoate concentration was measured in culture supernatants using
absorbance at 225 nm. See Fig. 2-S8 for growth conditions and profiles.
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Figure 2-S12: Vanillate (VAN) consumption profiles of WT and PVHG6 strains grown in
different VAN concentrations. A. 1.25 g/L. B. 1.5 g/L. C. 1.75 g/L. D. 2 g/L. E. 2.25 g/L. F. 2.5
g/L. Points represent the average of three biological replicates and error bars represent one standard
deviation. Vanillate concentration was measured in culture supernatants using absorbance at 284
nm. See Fig. 2-S8 for growth conditions and profiles.
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Figure 2-S13: 4-hydroxybenzoate (HBA) consumption profiles of WT and PVHG6 strains
grown in different HBA concentrations. A. 2 g/L. B. 2.25 g/L. C. 2.5 g/L. D. 2.75 g/L. E. 3 g/L.
F. 3.25 g/L. Points represent the average of three biological replicates and error bars represent one
standard deviation. 4-hydroxybenzoate concentration was measured in culture supernatants using
absorbance at 244 nm. See Fig. 2-S8 for growth conditions and profiles.
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Figure 2-S14: Growth of WT and PVHG6 strains on 1 g/L glucose. Cells were initially cultured
in 2 mL of minimal medium A supplemented with 0.2 g/L of sodium benzoate, phenol, guaiacol,
4-hydroxybenzoate, and vanillate (1 g/L total aromatics) and 1 g/L ammonium sulfate for 24 hours,
and then subcultured into 10 mL of the same media for 24 hours to an OD600 of ~0.5. Cultures
were grown in 10 mL of minimal medium A supplemented with 1 g/L glucose as the carbon source
and 1 g/L ammonium sulfate as the nitrogen source with an initial OD600 of 0.05. Points represent
the average of three biological replicates and error bars represent one standard deviation.
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Figure 2-S15: Principal component analysis of all WT and PVHG6 transcriptomes. Principal
component analysis was done using normalized counts of all genes in R. opacus. Glc = 1 g/L
glucose, Multi = 0.5 g/L of PHE, VAN, HBA, GUA, and BEN (2.5 g/L total aromatics). Other
compounds listed in legend were used at a concentration of 0.5 g/L. For Glc and Multi, t1 represents
cells harvested at early exponential phase (10 hours for Glc; 20 hours for Multi), while t2 represents
cells harvested at mid-exponential phase (13 hours for Glc, 32 hours for Multi). Samples from
individual compound growth conditions were harvested at mid-exponential phase (24 hours for
WT PHE and 21 hours for PVHG6 PHE; 19 hours for WT and PVHG6 GUA; 11 hours for WT
and PVHG6 HBA; 12 hours for WT and PVHG6 BEN; 24 hours for WT and PVHG6 VAN). All
transcriptomics experiments were performed in minimal medium A. Each symbol represents a
biological replicate. Analysis was performed with normalized counts using the variance stabilizing
transformation from the DESeq2 software package. PC1 = 1st principal component and PC2 = 2nd
principal component. PHE = phenol, VAN = vanillate, HBA = 4-hydroxybenzoate, GUA =
guaiacol, and BEN = sodium benzoate.
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Figure 2-S16: Principal component analysis of all WT and PVHG6 transcriptomes with
Plasmids 1 and 2 removed. Principal component analysis was done using normalized counts of
all genes in R. opacus except those located on Plasmids 1 and 2. Glc = 1 g/L glucose, Multi = 0.5
g/L of PHE, VAN, HBA, GUA, and BEN (2.5 g/L total aromatics). Other compounds listed in
legend were used at a concentration of 0.5 g/L. For Glc and Multi, t1 represents cells harvested at
early exponential phase (10 hours for Glc; 20 hours for Multi), while t2 represents cells harvested
at mid-exponential phase (13 hours for Glc, 32 hours for Multi). Samples from individual
compound growth conditions were harvested at mid-exponential phase (24 hours for WT PHE and
21 hours for PVHG6 PHE; 19 hours for WT and PVHG6 GUA; 11 hours for WT and PVHG6
HBA; 12 hours for WT and PVHG6 BEN; 24 hours for WT and PVHG6 VAN). All
transcriptomics experiments were performed in minimal medium A. Each symbol represents a
biological replicate. Analysis was performed with normalized counts using the variance stabilizing
transformation from the DESeq2 software package. PC1 = 1st principal component and PC2 = 2nd
principal component. PHE = phenol, VAN = vanillate, HBA = 4-hydroxybenzoate, GUA =
guaiacol, and BEN = sodium benzoate.
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Figure 2-S17: Expression of the top 30 most upregulated genes in PVHG6 compared to the
WT strain in the mixture of lignin model compounds. Glc = 1 g/L glucose, PHE = 0.5 g/L
phenol, VAN = 0.5 g/L vanillate, HBA = 0.5 g/L 4-hydroxbenzoate, GUA = 0.5 g/L guaiacol,
BEN = 0.5 g/L sodium benzoate, and Multi = 0.5 g/L of phenol, vanillate, 4-hydroxybenzoate,
guaiacol, and sodium benzoate (2.5 g/L total aromatics). t1 represents cells harvested at early
exponential phase (10 hours for Glc; 20 hours for Multi), while t2 represents cells harvested at midexponential phase (13 hours for Glc; 32 hours for Multi). Samples from individual compound
growth conditions were harvested at mid-exponential phase (24 hours for WT PHE, 21 hours for
PVHG6 PHE, 19 hours for WT and PVHG6 GUA, 11 hours for WT and PVHG6 HBA, 12 hours
for WT and PVHG6 BEN, and 24 hours for WT and PVHG6 VAN). All transcriptomics
experiments were performed in minimal medium A. Raw counts were transformed using the
variance stabilizing transformation in DESeq2. Darker colors indicate higher normalized counts
(see scale bar). Gene codes are from the NCBI reference sequence NZ_CP003949.1.
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Figure 2-S18: Growth of transporter knockout mutants compared to that of the WT strain
using aromatic carbon sources. Cells were initially cultured in 2 mL of minimal medium A
supplemented with 0.2 g/L of sodium benzoate, phenol, guaiacol, 4-hydroxybenzoate, and
vanillate (1 g/L total aromatics) and 1 g/L ammonium sulfate for 24 hours, and then subcultured
into 10 mL of the same media for 24 hours to an OD600 of ~0.5. For all data shown, cultures were
grown in 10 mL of minimal medium A supplemented with 1 g/L ammonium sulfate as the
nitrogen source and the carbon source as indicated in the figure with an initial OD600 of 0.05.
Bars represent the average of three biological replicates and error bars represent one standard
deviation. PHE = phenol, VAN = vanillate, HBA = 4-hydroxybenzoate, GUA = guaiacol, BEN =
sodium benzoate, and Mix = 0.5 g/L of PHE, VAN, HBA, GUA and BEN (2.5 g/L total
aromatics). ∆ShikiT = RS31355 knockout mutant, ∆BenT = RS30810 knockout mutant, and
∆VanT = RS33590 knockout mutant.
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RS21455 3-hexulose-6-phosphate isomerase
RS21460 3-hexulose-6-phosphate synthase
RS21465 Ethyl tert-butyl ether degradation protein
RS21470 Hypothetical protein
RS21475 Cytochrome P450
RS21480 Ferredoxin
RS21485 Hypothetical protein
RS21490 Hypothetical protein
RS21495 AraC family transcriptional regulator
RS21500 Glucose-6-phosphate dehydrogenase
RS21505 6-phosphogluconate dehydrogenase

WT

Multi t2

BEN

Multi t1

GUA

HBA

PHE

VAN

Glc t2

Glc t1

Multi t2

BEN

Multi t1

GUA

VAN

HBA

PHE

Glc t2

Glc t1

RS21510 AraC family transcriptional regulator

PVHG6

Figure 2-S19: Putative C1 metabolism during growth on vanillate and guaiacol. Heat map of
normalized gene expression counts for genes putatively involved in C1 metabolism. Glc = 1 g/L
glucose, PHE = 0.5 g/L phenol, VAN = 0.5 g/L vanillate, HBA = 0.5 g/L 4-hydroxbenzoate, GUA
= 0.5 g/L guaiacol, BEN = 0.5 g/L sodium benzoate, and Multi = 0.5 g/L of phenol, vanillate, 4hydroxybenzoate, guaiacol, and sodium benzoate (2.5 g/L total aromatics). t1 represents cells
harvested at early exponential phase (10 hours for Glc; 20 hours for Multi), while t2 represents
cells harvested at mid-exponential phase (13 hours for Glc; 32 hours for Multi). Samples from
individual compound growth conditions were harvested at mid-exponential phase (24 hours for
WT PHE, 21 hours for PVHG6 PHE, 19 hours for WT and PVHG6 GUA, 11 hours for WT and
PVHG6 HBA, 12 hours for WT and PVHG6 BEN, and 24 hours for WT and PVHG6 VAN). All
transcriptomics experiments were performed in minimal medium A. Raw counts were transformed
using the variance stabilizing transformation in DESeq2. Darker colors indicate higher normalized
counts (see scale bar). Gene codes are from the NCBI reference sequence NZ_CP003949.1.
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Normalized Counts

RS01890 Superoxide dismutase
RS02790 Hypothetical protein
RS11630 Acyl-CoA dehydrogenase
RS13070 Non-ribosomal peptide synthetase
RS14345 DeoR family transcriptional regulator
RS14470 Aspartate aminotransferase
RS14825 Cytochrome ubiquinol oxidase subunit I
RS22580 MFS transporter
RS28090 FAD-binding dehydrogenase
RS32480 Phosphotransferase
RS35615 Peptidase
RS35795 Two component sensor histidine kinase
RS36560 Membrane protein
RS37785 Oxidoreductase
RS37790 Hypothetical protein
RS37805 Amino acid permease
RS37810 3-oxo-acyl reductase
RS37815 Oxidoreductase
RS37820 Oxidoreductase
RS37840 Serine/threonine protein kinase
RS41665 Succinate semialdehyde dehydrogenase

WT

Multi t2

Multi t1

BEN

HBA

GUA

VAN

PHE

Glc t2

Glc t1

Multi t2

Multi t1

BEN

GUA

HBA

VAN

PHE

Glc t2

Glc t1

RS39015 Serine/threonine protein kinase

PVHG6

Figure 2-S20: Expression of genes with SNPs in PVHG6. Heat map of normalized gene
expression counts for genes with SNPs in PVHG6. Glc = 1 g/L glucose, PHE = 0.5 g/L phenol,
VAN = 0.5 g/L vanillate, HBA = 0.5 g/L 4-hydroxbenzoate, GUA = 0.5 g/L guaiacol, BEN = 0.5
g/L sodium benzoate, and Multi = 0.5 g/L of phenol, vanillate, 4-hydroxybenzoate, guaiacol, and
sodium benzoate (2.5 g/L total aromatics). t1 represents cells harvested at early exponential phase
(10 hours for Glc; 20 hours for Multi), while t2 represents cells harvested at mid-exponential phase
(13 hours for Glc; 32 hours for Multi). Samples from individual compound growth conditions were
harvested at mid-exponential phase (24 hours for WT PHE, 21 hours for PVHG6 PHE, 19 hours
for WT and PVHG6 GUA, 11 hours for WT and PVHG6 HBA, 12 hours for WT and PVHG6
BEN, and 24 hours for WT and PVHG6 VAN). All transcriptomics experiments were performed
in minimal medium A. Raw counts were transformed using the variance stabilizing transformation
in DESeq2. Darker colors indicate higher normalized counts (see scale bar). Gene codes are from
the NCBI reference sequence NZ_CP003949.1.
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Normalized Counts

RS01890 Superoxide dismutase
RS08140 Phosphoenolpyruvate carboxykinase
RS10095 Fructose bisphosphate aldolase
RS14825 Cytochrome ubiquinol oxidase subunit I
RS21245 Non-ribosomal peptide synthease
RS32480 Phosphotransferase
RS37125 Non-ribosomal peptide synthease
RS37785 Oxidoreductase
RS37790 Hypothetical protein
RS37795 Hypothetical protein
RS37805 Amino acid permease
RS37810 3-oxoacyl-ACP reductase
RS37815 Oxidoreductase
RS37820 Oxidoreductase
RS37840 Serine/threonine protein kinase
RS42725 Hypothetical protein
RS38565 Succinate semialdehyde dehydrogenase
RS41665 Succinate semialdehyde dehydrogenase
RS38570 Oxidoreductase

WT

Multi t2

Multi t1

BEN

GUA

VAN

HBA

PHE

Glc t1

Glc t2

Multi t2

Multi t1

BEN

GUA

HBA

PHE

VAN

Glc t2

Glc t1

RS39015 Serine/threonine protein kinase

PVHG6

Figure 2-S21: Expression of genes with SNPs in PVHG6. Heat map of normalized gene
expression counts for genes with SNPs in PVHG6. Glc = 1 g/L glucose, PHE = 0.5 g/L phenol,
VAN = 0.5 g/L vanillate, HBA = 0.5 g/L 4-hydroxbenzoate, GUA = 0.5 g/L guaiacol, BEN = 0.5
g/L sodium benzoate, and Multi = 0.5 g/L of phenol, vanillate, 4-hydroxybenzoate, guaiacol, and
sodium benzoate (2.5 g/L total aromatics). t1 represents cells harvested at early exponential phase
(10 hours for Glc; 20 hours for Multi), while t2 represents cells harvested at mid-exponential phase
(13 hours for Glc; 32 hours for Multi). Samples from individual compound growth conditions were
harvested at mid-exponential phase (24 hours for WT PHE, 21 hours for PVHG6 PHE, 19 hours
for WT and PVHG6 GUA, 11 hours for WT and PVHG6 HBA, 12 hours for WT and PVHG6
BEN, and 24 hours for WT and PVHG6 VAN). All transcriptomics experiments were performed
in minimal medium A. Raw counts were transformed using the variance stabilizing transformation
in DESeq2. Darker colors indicate higher normalized counts (see scale bar). Gene codes are from
the NCBI reference sequence NZ_CP003949.1.
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Figure 2-S22: Calibration curves for estimation of lignin model compound concentrations.
Wavelength used for each calibration curve is listed on the x-axis of each plot, and the fitted
correlation equation used to calculate concentrations are listed in each plot. A. Guaiacol calibration
curve. B. Phenol calibration curve. C. 4-hydroxybenzoate calibration curve. D. Vanillate
calibration curve. E. Sodium benzoate calibration curve. For A-D, measurements were performed
by diluting 5 g/L stock solutions prepared in minimal medium A with no carbon or nitrogen sources
and then measuring absorbance using a TECAN Infinite M200 Pro plate reader in a UV transparent
96 well plate. For E, dilutions were performed in the same way, but absorbance was measured
using a Nanodrop 2000 with a quartz cuvette. See Materials and Methods for more information
about measurement of lignin model compounds. PHE = phenol, GUA = guaiacol, VAN = vanillate,
HBA = 4-hydroxybenzoate, BEN = sodium benzoate.
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Table 2-S1: Adaptive evolution summary. Concentrations listed are final concentrations from
adaptation. PCA = protocatechuate, GUA = guaiacol, PHE = phenol, HBA = 4-hydroxybenzoate,
VAN = vanillate, BEN = sodium benzoate, and GLC = glucose. * No.: 3 = P, 14 = PV, 25 = PVH,
27 = PVHG, 32 = High glucose, and 33 = B.

No.*

# of
subcultures

PCA
(g/L)

GUA
(g/L)

PHE
(g/L)

HBA
(g/L)

VAN
(g/L)

BEN
(g/L)

GLC
(g/L)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33

40
83
80
60
48
56
63
60
62
62
42
59
58
71
56
64
64
74
60
74
74
101
70
79
67
54
104
50
42
57
60
72
80

4.58
2.85
3.32
2.63
3.24
1.34
2.91
3.18
2.14
3.19
2.26
1.36
1.54
2.99
1.52
1.51
-

1.67
0.47
0.64
0.30
1.10
0.22
0.48
0.53
0.59
0.34
0.66
0.23
0.49
0.50
0.25
0.25
-

1.50
0.55
0.64
1.05
1.16
0.22
0.36
0.53
0.59
0.34
0.49
0.23
0.49
0.26
0.50
0.25
-

3.09
0.88
1.06
1.05
1.41
0.48
0.36
0.75
1.19
1.33
0.98
0.45
0.98
0.51
0.51
0.50
-

2.06
1.08
1.10
1.16
1.41
0.53
0.53
0.38
0.69
1.33
0.98
0.98
0.51
1.00
0.51
0.50
-

12.58

419.0
-
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Total
aromatics
(g/L)
4.58
1.67
1.50
3.09
2.06
3.32
3.87
3.51
4.32
1.27
1.36
2.19
2.09
2.32
2.82
1.78
3.88
4.25
2.86
4.25
3.39
2.37
1.37
3.32
2.44
2.26
2.95
2.82
4.98
2.78
3.02
0
12.58

Table 2-S2: Summary of comparative genomics of adapted strains. SNPs = single nucleotide
polymorphisms; INDELs = insertions or deletions.

Sample

Total # of
SNPs

# of Nonsynonymous
SNPs

# of
Intergenic
SNPs

# of Silent
SNPs

# of Small
INDELs

Plasmid 1
Deletions

Plasmid 2
Loss

P1
P2
P3
P4
P5
P6
PV1
PV2
PV3
PV4
PV5
PV6
PVH1
PVH2
PVH3
PVH5
PVH6
PVHG1
PVHG2
PVHG3
PVHG4
PVHG5
PVHG6
B1
B2
B3
B4
B5
B6
Glc1
Glc2
Glc3
Glc4
Glc5
Glc6

42
45
51
46
44
50
29
29
36
28
30
34
43
36
44
45
33
28
28
45
26
43
45
3
21
10
14
46
18
30
8
28
27
7
32

13
16
20
15
13
16
9
9
9
8
10
11
17
14
18
19
15
16
17
19
16
17
19
2
13
6
6
20
13
17
5
14
13
4
20

3
3
3
3
4
4
1
1
3
1
1
2
2
2
2
2
1
2
2
4
1
2
2
0
1
2
2
3
2
2
1
3
2
1
2

26
26
28
28
27
30
19
19
24
19
19
21
24
20
24
24
17
10
9
22
9
24
24
1
7
2
6
23
3
11
2
11
12
2
10

1
1
1
1
1
1
0
1
0
0
0
1
1
1
2
2
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0

No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
Yes
Yes
Yes
Yes
Yes
Yes
No
No
No
No
Yes
No
Yes
No
Yes
Yes
No
Yes

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
No
No
Yes
No
No
No
No
No
No
No
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Table 2-S3: INDELs in adapted strains. INDELs were identified using Pilon variant calling,
filtered with GATK, and verified with de novo assembly of the sequenced reads using SPAdes.
Putative annotations are from NCBI reference sequence NC_CP003949.1. See Materials and
Methods for more information. “All” indicates all sequenced strains isolated from the indicated
adaptation condition. Strain names indicate adaptation condition from which the strain originated:
P = phenol adaptation condition, PV = phenol and vanillate adaptation condition, PVH = phenol,
vanillate, and 4-hydroxybenzoate adaptation condition, and PVHG = phenol, vanillate, 4hydroxybenzoate, and guaiacol adaptation condition. Base Mean Expression is the average of the
normalized counts from WT and PVHG6 transcriptomic data from all growth conditions.
Strains

Gene ID

All PVHG, All PVH

RS03610

PV2
All P

RS18950
RS20545

PV6

RS31910

PVH3, PVH5

RS40520

Annotation
penicillin binding
protein
hypothetical protein
hypothetical protein
helix-turn-helix
transcriptional regulator
hypothetical protein
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Type

Location

Base Mean
Expression

Insertion (1 bp)

Chromosome

8,100

Insertion (5 bp)
Deletion (100 bp)

Chromosome
Chromosome

334
18

Insertion (1 bp)

Chromosome

753

Insertion (1 bp)

Plasmid 8

116

Table 2-S4: Shared SNPs between strains isolated from the same adaptation condition.
Genes with non-synonymous and intergenic SNPs that are shared between strains isolated from
the same adaptation condition are shown. For intergenic SNPs, the nearest gene in each direction
is listed. Some genes have more than one shared SNP.
Adaptation
Condition
P

PV

PVH

PVHG

B
Glc

Gene ID

Annotation

RS01890/RS41735
superoxide dismutase/hypothetical protein
RS14825
cytochrome ubiquinol oxidase subunit I
RS21470
hypothetical protein
RS37785/RS37790 SDR family mycofactocin-dependent oxidoreductase/hypothetical protein
RS37790
hypothetical protein
RS37795
hypothetical protein
RS37805
amino acid permease
RS37810
3-oxoacyl-ACP reductase
RS37810/RS37815
3-oxoacyl-ACP reductase/LLM class flavin-dependent oxidoreductase
RS37870
exoribonuclease II
RS01890
superoxide dismutase
RS10095
class II fructose-bisphosphate aldolase
RS14825
cytochrome ubiquinol oxidase subunit I
RS42075
hypothetical protein (pseudogene)
RS37805
amino acid permease
RS37810
3-oxoacyl-ACP reductase
RS37810/RS37815
3-oxoacyl-ACP reductase/LLM class flavin-dependent oxidoreductase
RS00415
AMP-dependent synthetase
RS02720
membrane protein
RS02835
ammonia channel protein
RS08140
phosphoenolpyruvate carboxykinase
RS11540
4-hydroxy-2-oxovalerate aldolase
RS14825
cytochrome ubiquinol oxidase subunit I
RS25200
L-ectoine synthase
RS27825
alpha/beta hydrolase
RS37805
amino acid permease
RS37810
3-oxoacyl-ACP reductase
RS37810/RS37815
3-oxoacyl-ACP reductase/LLM class flavin-dependent oxidoreductase
RS01890
superoxide dismutase
RS11630
acyl-CoA dehydrogenase
RS13070
non-ribosomal peptide synthetase
RS14825
cytochrome ubiquinol oxidase subunit I
RS22580
MFS transporter
RS32480
phosphotransferase
RS35615
peptidase
RS37785/RS37790 SDR family mycofactocin-dependent oxidoreductase/hypotheical protein
RS37790
hypothetical protein
RS39015
serine/threonine-protein kinase PknK
RS03790
cold-shock protein
RS08140
phosphoenolpyruvate carboxykinase
RS13475
glutamine--fructose-6-phosphate aminotransferase
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RS15825
RS24210

LysR family transcriptional regulator
alpha-(1 6)-mannopyranosyltransferase A

68

Table 2-S5: Genes with non-synonymous SNPs or intergenic SNPs found across multiple
adaptation experiments (including the glucose adaptation experiment). For intergenic SNPs,
the nearest gene in each direction is listed. Some genes have more than one shared SNP. Putative
annotations are from NCBI reference sequence NZ_CP003949.1. “All” indicates that all
sequenced strains isolated from the indicated adaptation condition contain either non-synonymous
SNPs or intergenic SNPs that could affect gene expression. Base Mean Expression is the average
of the normalized counts from WT and PVHG6 transcriptomic data from all growth conditions.

Strains

Gene
ID

Annotation

Location

Base Mean
Expression

All P, All PV, PVH6, All PVHG

RS01890

superoxide dismutase

Chromosome

32,010

All B, All PVH

RS08140

phosphoenolpyruvate carboxykinase

Chromosome

30,198

P2, P3, P6, All PV

RS10095

class II fructose-bisphosphate aldolase

Chromosome

5,291

All P, All PV, All PVH, All PVHG

RS14825

cytochrome ubiquinol oxidase subunit I

Chromosome

23,629

PV5, B2, Glc6

RS21245

non-ribosomal peptide synthetase

Chromosome

110

PV3, All PVHG

RS32480

phosphotransferase

Chromosome

285

RS37785/

intergenic
Plasmid 1

8/103

RS37790

(oxidoreductase/hypothetical protein)

RS37790

hypothetical protein

Plasmid 1

103

RS37795

hypothetical protein

Plasmid 1

17

RS37805

amino acid permease

Plasmid 1

278

RS37810

3-oxoacyl-ACP reductase

Plasmid 1

26

Plasmid 1

26/374

Plasmid 1

24

Plasmid 1

6

All P, PV3, B5, Glc1, Glc3, Glc4, Glc6
All P, PVH3, All PVHG, B5, Glc1,
Glc3, Glc4, Glc6
All P, B5, Glc1, Glc3, Glc4, Glc6
All P, All PV, All PVH, PVHG3,
PVHG5, PVHG6, B4, B5, Glc1, Glc3,
Glc4, Glc6
All P, All PV, All PVH, PVHG3,
PVHG5, PVHG6, B5, Glc1, Glc3,
Glc4, Glc6
All P, All PV, All PVH, PVHG3,
RS37810/

intergenic

RS37815

(3-oxoacyl-ACP reductase/oxidoreductase)

PVHG5, PVHG6, B5, Glc1, Glc3,
Glc4, Glc6
P2, P3, P4, P5,P6, PVHG2,PVHG4,

NAD-dependent succinate-semialdehyde
RS38565

B3, B4, Glc1, Glc3, Glc6

dehydrogenase (pseudogene)

P1, P2, P3, P4, P6, PV6, PVHG2,
NAD-dependent succinate-semialdehyde
PVHG4, PVHG5, PVHG6, B3, B4, B5,

RS41665
dehydrogenase (pseudogene)

B6, Glc1, Glc3, Glc6
P5, PV3, PVH3, PVH5, B6

RS38570

FAD-binding oxidoreductase (pseudogene)

Plasmid 1

60

P2, P3, P4, P5, P6, All PVHG

RS39015

serine/threonine-protein kinase PknK

Plasmid 3

354
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Table 2-S6: Phyre2 results for cytochrome ubiquinol oxidase I (RS14825). The native protein
was
modeled
using
the
Protein
Homology/analogY
Recognition
Engine
(www.sbg.bio.ic.ac.uk/~phyre2/). 96% of residues were modeled at >90% confidence using the
template protein 2YEV. Mutational sensitivity is defined as the likelihood of an amino acid change
to affect function and is calculated on a scale of 0-9 (9 = the most sensitive).

All P, All PVHG

SNP
Change
G to A

All PV

T to C

I309 to T

5

Transmembrane helix

No

All PVH

T to G

F366 to V

8

Transmembrane helix

No

Strain

AA
Predicted Mutational
Change
Sensitivity
A272 to T
6

Predicted Secondary
Structure Location
Transmembrane helix

Located in
binding pocket?
Yes

Table 2-S7: Phyre2 results for superoxide dismutase (RS01890). The native protein was
modeled
using
the
Protein
Homology/analogY
Recognition
Engine
(www.sbg.bio.ic.ac.uk/~phyre2/). 96% of residues were modeled at >90% confidence using the
template protein 1GN4. Mutational sensitivity is defined as the likelihood of an amino acid change
to affect function and is calculated on a scale of 0-9 (9 = the most sensitive).
Strain

SNP
Change

AA Change

Predicted Mutational
Sensitivity

Predicted Secondary
Structure Location

Located in
binding pocket?

All P

C to T

None, in
regulatory region

Not applicable

Not applicable

Not applicable

All PV

A to C

V191 to G

8

Alpha helix

No

PVH6

A to G

V37 to G

7

Alpha helix

No

All PVHG

T to C

Y11 to C

8

None predicted

No

Table 2-S8: Growth characteristics of the WT and adapted strains using a mixture of lignin
model compounds as carbon sources (2.5 g/L total aromatics). Growth experiments were
performed in minimal medium A. Growth rates were calculated using at least four time points in
the log phase. Statistical significance was determined with a threshold of P < 0.05 using a one
mean, two-tailed Student’s t-test. Growth rate and OD600 values are shown as the average of three
biological replicates ± one standard deviation.
Strain

Growth rate (hr-1)

OD600 after
70 hr

Max OD600

Growth rate
significantly higher
than WT?

OD600 after 70 hr
significantly higher than
WT?

Max OD600 significantly
higher than WT?

WT

0.073 ± 0.001

0.54 ± 0.01

0.61 ± 0.01

not applicable

not applicable

not applicable

P1

0.084 ± 0.002

0.78 ± 0.02

0.81 ± 0.01

yes, P = 5.3 x 10-4

yes, P = 2.1 x 10-5

yes, P = 2.2 x 10-5

PV1

0.079 ± 0.002

0.82 ± 0.15

1.07 ± 0.13

yes, P = 0.0033

yes, P = 0.030

yes, P = 0.0034

PVH5

0.088 ± 0.001

0.55 ± 0.03

0.55 ± 0.03

yes, P = 7.2 x 10

-5
-6

PVHG6

0.088 ± 0.001

1.08 ± 0.02

1.08 ± 0.02

yes, P = 2.6 x 10

B2

0.085 ± 0.004

0.62 ± 0.03

0.69 ± 0.05

yes, P = 0.0086

70

no, P = 0.77
yes, P = 3.8 x 10
yes, P = 0.019

no, P = 0.053
-6

yes, P = 5.1 x 10-6
no, P = 0.073

Table 2-S9: Growth characteristics of the WT and adapted strains using a mixture of lignin
model compounds as carbon sources (3.0 g/L total aromatics). Growth experiments were
performed in minimal medium A. Growth rates were calculated using at least four time points in
the log phase. Statistical significance was determined with a threshold of P < 0.05 using a one
mean, two-tailed Student’s t-test. Growth rate and OD600 values are shown as the average of three
biological replicates ± one standard deviation.

0.42 ± 0.02

Growth rate
significantly higher
than WT?
not applicable

Max OD600
significantly higher
than WT?
not applicable

0.075 ± 0.001

0.73 ± 0.01

yes, P = 0.004

yes, P = 3.8 x 10-6

PV1

0.072 ± 0.004

0.74 ± 0.17

yes, P = 0.016

yes, P = 0.029

PVH5

0.073 ± 0.005

0.44 ± 0.04

yes, P = 0.021

no, P = 0.38

PVHG6

0.079 ± 0.001

0.77 ± 0.08

yes, P = 0.001

yes, P = 0.001

B2

0.077 ± 0.005

0.41 ± 0.04

yes, P = 0.011

no, P = 0.78

Strain

Growth rate
(hr-1)

Max OD600

WT

0.059 ± 0.004

P1

Table 2-S10: Half maximal inhibitory concentration (IC50) of individual lignin model
compounds for WT and PVHG6 strains. Growth experiments were performed in minimal
medium A. IC50 values were calculated using Prism (GraphPad Software, Inc.) with a fourparameter inhibitor response curve from OD600 measurements after 54 hours of growth. Statistical
significance was determined with a threshold of P < 0.05 using a one mean, two-tailed Student’s
t-test. IC50 values are shown as the average of three biological replicates ± one standard deviation.
Compound

WT IC50
(g/L)

PVHG6 IC50
(g/L)

Phenol

1.07 ± 0.05

Vanillate

2.12 ± 0.03

PVHG6 significantly different
from WT?

1.25 ± 0.01

PVHG6 vs. WT
difference (%)
17

2.00 ± 0.05

-6

yes, P = 0.025
no, P = 0.157
yes, P = 0.008
no, P = 0.055

4-hydroxybenzoate

2.71 ± 0.02

2.73 ± 0.01

1

Guaiacol
Sodium benzoate

1.64 ± 0.04
7.41 ± 0.31

1.90 ± 0.03
6.87 ± 0.16

16
-7

yes, P = 0.003

Table 2-S11: Data from genome sequencing and RNA-Seq performed in this study. See the
supplementary file at https://www.sciencedirect.com/science/article/pii/S1096717618300910 for
Tables.
Tab 1: All SNPs in adapted strains organized by strain.
Tab 2: All SNPs in adapted strains organized by genome order.
Tab 3: All INDELs in adapted strains.
Tab 4: Summary of transcriptomic data for genes with mutations, β-ketoadipate pathway
genes, funneling pathway genes, aromatic transporter genes, and C1 metabolism genes.
Tabs 5-26: Comparison of gene expression between samples using DESeq2.
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Table 2-S12: Homology of RS34105 and RS34095 (upregulated in PVHG6 compared to WT)
to putative 3-oxoadipyl-CoA thiolases. R. opacus PD630 proteins were compared to the R.
opacus PD630 proteome and the R. jostii RHA1 proteome using NCBI blastp
(https://blast.ncbi.nlm.nih.gov/Blast.cgi). The E value represents the number of hits expected by
random chance when searching the database (the smaller value, the more significant match). The
amino acid positive percent identity between each protein pair is reported as the number of
identical or physically similar amino acids. If the protein has been characterized and named, the
name is listed under notes.
R. opacus Gene code

Gene code

Pd630_RS34105

RHA1_ro02517
RHA1_ro01340
RHA1_ro02863
Pd630_RS31575
Pd630_RS25375
RHA1_ro02517
RHA1_ro01340
RHA1_ro02863
Pd630_RS31575
Pd630_RS25375

Pd630_RS34095

Amino Acid Positive
% Identity
306/403 (75%)
309/406 (76%)
220/417 (52%)
303/401 (75%)
309/406 (76%)
261/394 (66%)
259/403 (64%)
229/412 (55%)
262/396 (66%)
259/403 (64%)

E value

Notes

0
0
5e-81
0
0
3e-139
2e-127
2e-70
1e-135
1e-123

CatF
PcaF
PaaE
N/A
N/A
CatF
PcaF
PaaE
N/A
N/A

Table 2-S13: Homology of aromatic degradation enzymes in Rhodococcus opacus PD630 to
enzymes in Rhodococcus jostii RHA1 and Rhodococcus opacus 1CP. Protein sequences from
R. opacus PD630 were compared to the R. jostii RHA1 and R. opacus 1CP protein sequences using
NCBI blastp (https://blast.ncbi.nlm.nih.gov/Blast.cgi). The E value represents the number of hits
expected by random chance when searching the database (the smaller value, the more significant
match). The amino acid positive percent identity between each protein pair is reported as the
number of identical or physically similar amino acids. If the protein has been characterized and
named, the name is listed under notes.
Fig. 2-5 genes (R. jostii RHA1)
R. opacus PD630
gene code
RS31555
RS31560
RS30765
RS30770
RS02665

Putative annotation
Two-component phenol hydroxylase,
reductase component
Two-component phenol hydroxylase,
oxygenase component
Two-component phenol hydroxylase,
reductase component
Two-component phenol hydroxylase,
oxygenase component
Putative vanillate demethylase, reductase
component

R. jostii RHA1
gene code

R. jostii % positive
identity

R. jostii
E value

Notes

RHA1_ro02513

189/190 (99%)

3E-139

PheA2

RHA1_ro02514

537/538 (99%)

0

PheA1

RHA1_ro02379

184/186 (98%)

5E-139

N/A

RHA1_ro02380

535/538 (99%)

0

N/A

RHA1_ro04163

308/319 (96%)

0

N/A

RS02670

Hypothetical protein

RHA1_ro04164

69/71 (97%)

3E-33

N/A

RS02675

Putative vanillate demethylase, oxygenase
component

RHA1_ro04165

352/354 (99%)

0

N/A

RS31670

TetR family transcriptional regulator

RHA1_ro02538

208/208 (100%)

6E-150

N/A

RS31675

4-hydroxybenzoate 3-monooxygenase

RHA1_ro02539

390/392 (99%)

0

N/A

RS30780

Cytochrome P450

RHA1_ro02382

401/403 (99%)

0

N/A

RS30785

Putative cytochrome P450 reductase

RHA1_ro02383

320/329 (97%)

0

N/A
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RS21470

Hypothetical protein

RHA1_ro02514

63/75 (84%)

3E-32

N/A

RS21475

Cytochrome P450

RHA1_ro08068

380/440 (86%)

0

N/A

RS21480

Putative cytochrome P450 reductase

RHA1_ro11319

284/323 (87%)

0

N/A

RS21485

Hypothetical protein

none

N/A

N/A

N/A

RS30790

Benzoate 1,2 dioxygenase subunit A

RHA1_ro02384

458/458 (100%)

0

BenA

Benzoate 1,2 dioxygenase subunit B

RHA1_ro02385

167/169 (98%)

5E-124

BenB

RHA1_ro02386

508/512 (99%)

0

BenC

RHA1_ro02387

262/264 (99%)

0

BenD

RS30795
RS30800
RS30805

Benzoate 1,2 dioxygenase ferredoxin
reductase
3,5-cyclohexadiene-1,2-diol-1-carboxylate
dehydrogenase

Fig. 2-5 genes (R. opacus 1CP)
R. opacus PD630
gene code
RS31555
RS31560
RS30765
RS30770

Putative annotation
Two-component phenol hydroxylase,
reductase component
Two-component phenol hydroxylase,
oxygenase component
Two-component phenol hydroxylase,
reductase component
Two-component phenol hydroxylase,
oxygenase component

R. opacus 1CP
gene code

R. opacus 1CP %
positive identity

R. opacus
1CP
E value

Notes

R1CP_30420

188/190(98%)

7e-139

PheA2

R1CP_30425

536/538(99%)

0.0

PheA1

R1CP_29650

185/186(99%)

1e-139

N/A

R1CP_29655

534/538(99%)

0

N/A

RS31670

TetR family transcriptional regulator

R1CP_30540

207/208(99%)

3e-148

N/A

RS31675

4-hydroxybenzoate 3-monooxygenase

R1CP_30545

392/392(100%)

0

N/A

RS30790

Benzoate 1,2 dioxygenase subunit A

R1CP_29675

458/458 (100%)

0

BenA

RS30795

Benzoate 1,2 dioxygenase subunit B

R1CP_29680

169/169 (100%)

0

BenB

R1CP_29685

508/512 (99%)

0

BenC

R1CP_29690

262/264 (99%)

0

BenD

RS30800
RS30805

Benzoate 1,2 dioxygenase ferredoxin
reductase
3,5-cyclohexadiene-1,2-diol-1-carboxylate
dehydrogenase

Fig. 2-6 genes
R. opacus PD630
gene code
RS25340
RS25345

Putative annotation
Succinyl-CoA:3-ketoacid-CoA transferase
subunit A
Succinyl-CoA:3-ketoacid-CoA transferase
subunit B

R. jostii RHA1
gene code

R. jostii % Positive
identity

R. jostii
E value

Notes

RHA1_ro01333

212/213 (99%)

2E-155

PcaJ

RHA1_ro01334

249/249 (100%)

0

PcaI

RS25350

Protocatechuate 3,4-dioxygenase subunit A

RHA1_ro01335

230/233 (98%)

1E-173

PcaH

RS25355

Protocatechuate 3,4-dioxygenase subunit B

RHA1_ro01336

211/213 (99%)

2E-152

PcaG

RS25360

3-carboxy-muconate cycloisomerase

RHA1_ro01337

444/450 (98%)

0

PcaB

RS25365

3-oxoadipate enol-lactonase/4-carboxymuconolactone decarboxylase

RHA1_ro01338

393/400 (98%)

0

PcaC

RS25370

IcIR family transcriptional regulator

RHA1_ro01339

264/265 (99%)

0

PcaR

RS25375

Putative 3-oxoadipyl-CoA thiolase

RHA1_ro01340

401/403 (99%)

0

PcaF

RS31565

Catechol 1,2-dioxygenase

RHA1_ro02515

278/282 (98%)

0

CatA2

RS31570

Putative 3-oxoadipate enol-lactonase

RHA1_ro02516

257/264 (97%)

0

MhpC

RS31575

Putative 3-oxoadipyl-CoA thiolase

RHA1_ro02517

402/410 (98%)

0

CatF

RS30720

ROK family transcriptional regulator

RHA1_ro02370

396/397 (99%)

0

N/A

RS30725

Muconolactone delta-isomerase

RHA1_ro02371

92/93 (98%)

3E-65

CatC

RS30730

Muconate cycloisomerase I

RHA1_ro02372

370/373 (99%)

0

CatB

RS30735

Catechol 1,2-dioxygenase

RHA1_ro02373

279/280 (99%)

0

CatA

RS30745

Intradiol ring-cleavage dioxygenase

RHA1_ro02374

253/256 (98%)

0

CatR
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Table 2-S14: Lignin model compound concentrations for Fig. 2-2 seed cultures and colony
purification of adapted cultures. For the strains not used for Fig. 2, the listed concentrations can
be used for their seed cultures. PCA = protocatechuate, GUA = guaiacol, PHE = phenol, HBA =
4-hydroxybenzoate, VAN = vanillate, BEN = sodium benzoate, and GLC = glucose. * No.: 3 = P,
14 = PV, 25 = PVH, 27 = PVHG, 32 = High glucose, and 33 = B.
No.*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33

PCA
(g/L)
2
1
1
1
1
0.75
0.75
0.75
0.75
0.75
0.75
0.5
0.5
0.5
0.5
0.4
-

GUA
(g/L)
0.5
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
-

PHE
(g/L)
0.5
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
-

HBA
(g/L)
1
0.5
0.5
0.5
0.5
0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.1
-

74

VAN
(g/L)
1
0.5
0.5
0.5
0.5
0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.1
-

BEN
(g/L)
3

GLC
(g/L)
100
-

Table 2-S15: Lignin model compound concentrations for Fig. 2-2 subcultures. For the strains
not used for Fig. 2, the listed concentrations can be used for their subcultures. PCA =
protocatechuate, GUA = guaiacol, PHE = phenol, HBA = 4-hydroxybenzoate, VAN = vanillate,
BEN = sodium benzoate, and GLC = glucose. * No.: 3 = P, 14 = PV, 25 = PVH, 27 = PVHG, 32
= High glucose, and 33 = B.
No.*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33

PCA
(g/L)
2.29
1.42
1.66
1.32
1.62
0.67
1.45
1.59
1.07
1.59
1.13
0.68
0.77
1.49
0.76
0.75
-

GUA
(g/L)
0.84
0.24
0.32
0.15
0.55
0.11
0.24
0.27
0.30
0.17
0.33
0.11
0.25
0.25
0.13
0.13
-

PHE
(g/L)
0.75
0.28
0.32
0.52
0.58
0.11
0.18
0.27
0.30
0.17
0.24
0.11
0.25
0.13
0.25
0.13
-

HBA
(g/L)
1.54
0.44
0.53
0.52
0.70
0.24
0.18
0.38
0.59
0.66
0.49
0.23
0.49
0.26
0.25
0.25
-
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VAN
(g/L)
1.03
0.54
0.55
0.58
0.70
0.27
0.27
0.19
0.34
0.66
0.49
0.49
0.26
0.50
0.25
0.25
-

BEN
(g/L)
6.29

GLC
(g/L)
210
-

Table 2-S16: Summary of heterologous plasmids used in this work.
Plasmid
Name

Function

Backbone

Antibiotic

Length
(bp)

pDD120

pConstitutive.Che9c60.Che9c61

pB264

Kanamycin

6247

pDD163
pDD174
pDD175
pDD176
pDD177

RS30730 knockout vector
RS25360 knockout vector
RS30810 knockout vector
RS33590 knockout vector
RS031355 knockout vector

Integrative/p15a
Integrative/p15a
Integrative/p15a
Integrative/p15a
Integrative/p15a

Hygromycin B
Gentamicin
Hygromycin B
Hygromycin B
Hygromycin B

3268
4249
3373
3336
3327

Source
Delorenzo et al.
2018 [139]
This study
This study
This study
This study
This study

Table 2-S17: Summary of strains constructed using heterologous plasmids in Table 2-S16.
Strain
name

Genus

Species

Strain

Plasmid contained
or used

Corresponding
figure

DMD155

Escherichia

coli

DH10B

pDD120

N/A

DMD250

Escherichia

coli

DH10B

pDD163

N/A

DMD251

Rhodococcus

opacus

PD630

pDD163

Fig. 6C

DMD258

Escherichia

coli

DH10B

pDD177

N/A

DMD270

Escherichia

coli

DH10B

pDD174

N/A

DMD274

Escherichia

coli

DH10B

pDD175

N/A

DMD275

Escherichia

coli

DH10B

pDD176

N/A

DMD281

Rhodococcus

opacus

PD630

pDD174

Fig. 6D

DMD282

Rhodococcus

opacus

PD630

pDD177

Fig. S18

DMD283

Rhodococcus

opacus

PD630

pDD175

Fig. S18

DMD284

Rhodococcus

opacus

PD630

pDD176

Fig. S18
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Chapter 3

The microbiome and resistome of
chimpanzees, gorillas, and humans across
lifestyle and geography
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V.H.P. performed the experiments. T.P.C. analyzed the results. T.P.C, G.D., D.M., and C.S. wrote
the paper.

3.1 Abstract
The gut microbiome is generally stable but can vary across differences in host lifestyle,
geography, and host species. By comparing closely related host species across varying locations
and geography we can evaluate the relative contributions of these factors in structuring the
composition and functions of the microbiome. Here we show that the gut microbiome and
resistome of great apes and humans are more related by host lifestyle than geography. Using
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shotgun and functional metagenomics, we show that captive chimpanzees and gorillas have an
enrichment of microbial genera commonly found in non-Westernized humans despite living in
close geographic proximity to Westernized humans. Captive apes also maintain higher richness
and abundance of antibiotic resistance genes compared to wild apes. Finally, by comparing our
study cohorts to human gut microbiomes from a diverse range of environments and lifestyles, and
to other wild and captive gorilla cohorts, we find that the influence of host lifestyle is robust to
various geographic locations.

3.2 Introduction
From an anthropocentric view, the microbiomes of great apes provide a view to our
evolutionary past [140-142]. Gut microbial communities are generally stable, but they can be
altered in accordance with several factors including host lifestyle [140, 143-151], host species
[141, 142, 152], and geography [153-155]. By comparing microbial variation in wild and captive
great apes, we can approximate changes that occurred in human modernization as human
microbiomes were influenced by changes in lifestyle, including an increasingly Westernized diet
and increased antibiotic usage [140]. Such comparisons are also important for understanding the
impact of humans and their activities on great ape health. Anthropogenic threats such as poaching,
habitat encroachment, and diseases are the primary causes of population decrease in these
endangered Hominidae species, and the risk to great ape populations of exposure to human
activities continues to increase [154, 156-159].
The taxonomic composition of microbiomes of captive primates from the United States,
Southeast Asia, and Costa Rica have been shown to cluster with those of geographically separated
non-Westernized humans [143]. By synchronous sampling of a non-Westernized human cohort
that is sympatric with wild apes, we can test if their gut microbiomes vary predominantly by host
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species, lifestyle, or geographic distance [140, 160]. These findings can help guide conservation
efforts in endangered animals aimed at promoting microbiome configurations that are linked with
optimal host health and metabolism [161]. Such insight will not only inform the well-being of
captive populations but can lead to improved conservation outcomes in rehabilitation and
reintroduction programs [162].
Antibiotic exposure represents a key lifestyle-associated factor which can acutely and
persistently alter the gut microbiome [145, 151, 163]. Because of their ability to kill or inhibit the
growth of virtually all microbes, antibiotic treatments provide strong selection for enrichment of
antibiotic resistance genes (ARGs), selecting for and leading to an increasingly antibiotic resistant
bacterial composition [164, 165]. However, ARGs can also be found in bacteria from pristine
environments naïve to human-produced antibiotics, most likely due to the selection pressure
provided by natural antibiotic secretion from environmental bacteria and fungi over long
evolutionary time-scales [145, 166]. The discovery, and often indiscriminate usage, of antibiotics
in human and agricultural settings over the past century has selected for dramatic enrichment and
transmission of ARGs between environmental, commensal, and pathogenic microbes from diverse
habitats [145, 167]. Proactive identification of ARGs in environmental and host-associated
microbiomes allows for their characterization, tracking, and potential inhibition before they can
be exchanged with pathogens and found in the clinic [163, 168, 169]. Characterization of the
antibiotic resistome of wild and captive non-human primates can help approximate how the human
resistome may have changed in the antibiotic era, as well as assess the impact of human-contact
and captivity on the primate gut resistome [145, 151].
Here we compare the fecal microbiome taxonomic composition, microbial functional
pathways, and antibiotic resistome of wild and captive chimpanzees and gorillas, as well as
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humans living in the same geographical region as the wild apes. We also compare these cohorts
with human cohorts from around the world representing diverse lifestyles and geographies [144,
146, 147, 163, 170]. We hypothesize that the gut microbiomes, functional pathways, and
resistomes of sympatric humans and apes will be similar to each other since sharing of gut
microbiota between humans and wild and domestic animals living in geographic proximity has
been shown previously [154, 155, 171]. We further hypothesize that captive chimpanzees and
gorillas from zoos in the United States will be most similar to Westernized human microbiomes
because of human exposure and antibiotic treatment.
In this study we used high-throughput metagenomic sequencing to characterize the gut
microbiota and resistomes of 18 wild central chimpanzees (Pan troglodytes troglodytes) and 28
wild western lowland gorillas (Gorilla gorilla gorilla) from Nouabalé-Ndoki National Park in the
Republic of the Congo. These wild animals live in a remote area of the park that was completely
naïve to human impact before 2003 and identified as the ape population that was least disturbed
by humans in 2014 [172, 173]. We also collected samples from 81 humans living just outside of
the park, including some individuals that work within the park, in the Republic of the Congo. We
compared these cohorts to 18 chimpanzees and 15 western lowland gorillas from the St. Louis Zoo
(St. Louis, MO) and the Lincoln Park Zoo (Chicago, IL) in the United States. To tease apart the
contribution of lifestyle, location, and host species, our study includes two lifestyles (wild huntergatherer and non-Western human), two locations (USA and the Republic of the Congo), and three
host species (human, chimpanzee, and gorilla). To determine if our results are robust to further
differences in lifestyles and locations, we compared the fecal microbiomes from our samples to
published hunter-gatherer, rural agriculturalist, and urban human cohorts from the USA [146, 174],
Peru [146, 163], El Salvador [163], Malawi [144], Tanzania [147, 170], and Venezuela [144], and
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to published wild and captive gorilla cohorts from the Republic of the Congo, the USA, France,
and Switzerland [140, 175].

3.3 Results & Discussion
3.3.1 Taxonomic composition of the gut microbiome was predominantly
influenced by lifestyle
To test our hypothesis that the microbiomes of sympatric hosts will be the most similar,
we sequenced microbial metagenomic DNA from the fecal samples of our wild chimpanzee and
gorilla cohorts from the Republic of the Congo, humans living in close proximity, and captive
chimpanzees and gorillas from zoos in the USA. Overall, we generated 10.4 million sequences of
the V4 region of the 16S ribosomal RNA gene from 160 samples, which we analyzed as exact
amplicon sequence variants (ASVs). Through Principal Coordinates Analysis (PCoA), we found
that captive chimpanzees and gorillas clustered more closely with the non-Westernized humans
than their wild counterparts, indicating more human-like microbiomes (Figures 3-1A, 3-S1A).
Despite living in close geographic proximity, the humans, wild chimpanzees, and wild gorillas live
vastly different lifestyles as characterized by diet and antibiotic usage. Wild chimpanzees and
gorillas both eat natural plants and have some overlap in their diets, but chimpanzees are frugivores
while gorillas are predominantly folivores [176-178]. The humans in this study are rural
agriculturists and eat non-Westernized diets, high in plant fiber and low in animal protein, and are
exposed to antibiotic treatments that can further alter the gut microbiome [149, 179, 180]. The
captive apes have similar diets and a similar degree of antibiotic treatment as non-Westernized
humans which most likely drive the similarities in humans and captive apes [181]. This provides
evidence that host lifestyle is more influential to primate gut microbiome composition than either
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Figure 3-1: Taxonomic composition of the human, chimpanzee, and gorilla gut microbiomes.
(A) Principal-coordinate analysis (PCoA) plot of Bray-Curtis 16S metagenomic profiles from
individual human, chimpanzee, and gorilla fecal samples. (B) PCoA plot of Bray-Curtis 16S
metagenomic profiles from individual chimpanzee and gorilla fecal samples. (C) Boxplot of ASV
richness in host microbiomes (Kruskal-Wallis sum-rank test P < 3.8e-14; Wilcoxon rank sum test
with Benjamini-Hochberg correction P 7.7e-4). (D) Relative abundances of major bacteria phyla
for all individuals. (E) Cladogram of discriminatory taxa identified in human, chimpanzee, and
gorilla microbiome 16S data sets. Clades significantly enriched in human (red nodes), captive
chimpanzee (green nodes), captive gorilla (blue nodes), wild chimpanzee (purple nodes), and wild
gorilla (light blue nodes) metagenomes are indicated (LEfSe; linear discriminant analysis (LDA)
log score >4.5, P = 0.05).
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geography or host species. These findings are consistent with previous comparisons between
captive and wild douc and howler monkeys as well as comparisons between non-Westernized and
Westernized humans [143, 180].
The captive ape microbiomes all clustered more closely together than wild apes despite
being housed in two zoos ~500 km apart (Figure 3-1B). This finding is in contrast to a previous
study where the gut microbiomes of wild sympatric chimpanzees and gorillas were more similar
than wild allopatric apes [153]. Comparisons of sympatric and allopatric wild apes may be
confounded by the underlying changes in plants that are available for consumption in the different
locations. In contrast, the relatively limited diversity in human agriculture limits the diets for
captive apes and non-Westernized humans influencing their microbiomes to become more similar
[182]. Host species appeared to have some effect on the gut microbiome since wild and captive
chimpanzee microbiomes clustered more closely to humans than the respective wild and captive
gorillas. Chimpanzees are evolutionarily more closely related to humans than gorillas are, and that
relatedness is maintained in their gut microbiome in these findings [141, 142].
To identify differences in alpha diversity, we compared the species richness and Shannon
diversity of microbiomes in our cohort. We found that captive apes in the USA had higher richness
of ASVs (Figure 3-1C) following a geographic pattern, while humans and chimpanzees had higher
Shannon diversity than gorillas following a pattern of being influenced by host species (Figures 31C, 3-S1B). Shannon diversity takes into account species evenness, with lower Shannon values
indicating either decreased richness, decreased evenness, or both. Since captive apes have higher
species richness but similar Shannon values to wild apes, their microbiomes must contain a high
number of rare ASVs. Previous studies have reported that captivity is typically associated with a
decrease in microbiome richness, but in light of our findings there appears to be more nuance to
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that pattern depending on the population studied [143, 183]. In support of this, a previous study
found no significant difference in the Shannon diversity of wild and captive gorillas [175].
We used linear discriminant analysis effect size (LEfSe) [184] analysis to identify specific
taxa that are enriched in each host microbiome and found that captivity is associated with a higher
abundance of Prevotella (Bacteroidetes) and Treponema (Spirochaetes) for both chimpanzees and
gorillas (Figures 3-1D,E, 3-S1D,E). Prevotella was also found in high abundance in the Congolese
human microbiomes we sampled. Increased colonization of Prevotella and Treponema in captive
animal microbiomes and non-Westernized humans has been observed previously and is often
attributed to host diet [143, 149]. Species within the genus Prevotella are capable of plant
polysaccharide degradation, exhibiting ß-D-xylanase and ß-xylosidase activities which are
associated with hemicellulose degradation [143, 149]. Increased abundance of Prevotella in
captive apes suggests that their increased abundance may be caused by differences in the
composition of dietary polysaccharides compared to wild apes [143]. We were able to identify
three Treponema ASVs at the species level: Treponema succinifaciens, Treponema bryantii, and
Treponema berlinense. These species of Treponema are considered non-pathogenic commensals
that metabolize complex polysaccharides found in unprocessed plants [185, 186]. Commensal
Treponema species have been found in high abundance in human populations with nonWesternized lifestyles, including Hadza hunter-gatherers in Tanzania [148], Matses huntergatherers in the Peruvian Amazon [146],

humans practicing traditional agriculture in the

Tunapuco community of the Peruvian Andean highlands [146], and BaAka pygmies in the Central
African Republic [149]. Due to its presence in non-Westernized human populations and absence
in Westernized humans, Treponema has been postulated to be a member of the ancestral human
gut microbiome [149]. Low levels of Treponema present in our wild ape samples support this
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hypothesis since they indicate that this genus is naturally shared in our evolutionarily nearest living
relatives. The much higher abundance in captive apes compared to wild apes indicates that
Treponema species may be optimized to metabolize plant polysaccharides from the human diet
[146].
In contrast, wild chimpanzees were distinguished by higher relative recovery of
Coriobacteriaceae (Actinobacteria)

and

two

families

from

the

phylum

Firmicutes:

Erysipelotrichaceae and Lachnospiraceae (Figures 3-1E, 3-S1D). Wild gorillas had higher relative
recovery of Mogibacteriacea (Firmicutes) and SHD-231 (Chloroflexi), an under-characterized
bacterial genus found previously in wild western lowland gorilla microbiomes [140] (Figures 31D, 3-S1E). SHD-231 appears to be found only within the gorilla microbiome, indicating that it
may have co-evolved with the gorilla microbiome.

3.3.2 Functional pathways in the microbiome are relatively robust to changes
in individual taxa
To determine how differences in microbiome taxonomy altered functional potential, we
performed whole metagenome shotgun sequencing on all 160 fecal samples, rarefied the resulting
sequences to four million paired-end reads per sample, and annotated functional pathways using
HUMAnN2 [35]. We found that lifestyle had less influence on functional pathways in the
microbiome than on taxa (Figures 3-2A, 3-S2A,B). Functional pathways may be robust to changes
in taxa since many pathways are redundant across microbial taxa[35]. Using LEfSe, we identified
several discriminatory pathways that showed varying patterns of association with lifestyle and host
species (Figures 3-2B, 3-S2C). Captive and wild apes had higher relative recovery of branched
amino acid synthesis pathways (including isoleucine and valine) compared to humans, with
decreasing relative abundance from wild to captive apes and finally dropping further in humans
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(Figure 3-2B). This indicates that the non-Westernized lifestyle is associated with decreasing
branched amino acid synthesis but the large difference in ape and human relative abundance
indicates that host species also influences these changes. Congolese humans had the highest levels
of lysine and aromatic amino acid synthesis with relative abundance decreasing along both the
gradient of non-Westernized human to wild ape lifestyles, and host species relatedness with
relative abundance decreasing as the relatedness to humans decreased.

Figure 3-2: Functional pathway analysis of gut microbiota. (A) PCoA plot of Bray-Curtis
distances of the relative abundance of functional pathways from HUMAnN2 results. (B) Relative
abundance of functional pathways involved in amino acid synthesis, peptidoglycan synthesis, and
carbohydrate degradation (Kruskal-Wallis sum-rank test for all plots P 3.2E-9; Wilcoxon rank
sum test with Benjamini-Hochberg correction, for significant differences in all plots P 0.047).
The superpathway of purine synthesis I and adenosine synthesis was highest in the wild
gorillas and may be associated with the SHD-231 family, as a previous study also found increased
nucleotide sugar biosynthesis and purine nucleotide salvage pathways in gorilla microbiomes
dominated by SHD-231 [140]. We next investigated carbohydrate degradation pathways and found
that Congolese human microbiomes were enriched for the degradation of starch, galactose, and
stachyose. Again, we saw decreasing relative abundance of these pathways as host lifestyle
87

becomes more different from the non-Westernized human lifestyle. For galactose and stachyose
degradation, host species influenced relative recovery as captive and wild chimpanzees had no
difference in relative recovery, but wild gorillas had decreased abundances compared to captive
gorillas. The relative abundance of the starch degradation pathway shows a clear pattern of being
influenced by host lifestyle. Starch consumption is the main source of calories in humans, while
wild chimpanzees and gorillas consume low starch diets [181, 187]. Starch and carbohydrate
degradation have been linked with the presence of Treponema and Prevotella. These genera may
be the predominant taxa providing these functions in our cohorts since they are also enriched in
humans and captive apes in this study [140, 143].

3.3.3 Microbial resistome is primarily influenced by host lifestyle
To probe for antibiotic resistance genes (ARGs) that were putatively unique to our cohorts,
we used functional metagenomics, a method where metagenomic DNA fragments are cloned into
expression vectors, transformed into E. coli, and the resultant transformants are tested for
phenotypic resistance using antibiotic selection [12, 151, 163]. From our 160 samples, we created
16 functional libraries containing 50-123 gigabases of total insert DNA and screened them on 15
different antibiotics or antibiotic combinations resulting in the annotation of 332 ARGs (Figure 33A, Table 3-S1). We combined these resulting protein sequences with ARG protein sequences
from the Comprehensive Antibiotic Resistance Database (CARD) [188], and used ShortBRED
[36] to create unique markers for ARG identification in the 640 million shotgun metagenomic
reads (4 million per sample) originating from ape and human fecal DNA. We found that captive
apes clustered more closely to humans than wild apes for both abundance and presence of ARGs
(Figures 3-3A,B, 3-S3D,E) and, similar to our taxonomic results, captive ape resistomes clustered
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more closely together than wild apes (Figures 3-3B,C). This provides evidence that host lifestyle
influences the gut resistome more than geography or host species for the studied primates.
Aminoglycoside resistance genes represented more than 50% of the wild ape gut
resistomes (Figure 3-3C). Aminoglycosides are produced naturally in the environment by several
soil bacteria and inhibit protein synthesis by binding to the ribosome [189]. The specific
aminoglycoside resistance genes we found enriched in wild apes were identified as AAC(3)-VIIa,
an acetyltransferase that inactivates aminoglycosides [189], and FmrO ribosomal RNA
methyltransferases [190] that were identified from our functional selections. Ribosomal
methyltransferases provide aminoglycoside resistance by methylation of the ribosome that
prevents aminoglycoside binding and thus resistance [191]. The overall abundance and richness
of ARGs in wild apes was extremely low compared to humans and captive apes (Figure 3-3D). In
captive apes and humans, tetracycline resistance genes were the most abundant with beta-lactams
also making up a large proportion of the resistome (Figure 3-3C). Tetracyclines and beta-lactams
are both broad-spectrum antibiotics and are popular first-line antibiotics in human infectious
disease treatment [192]. Tetracycline resistance in the human and captive ape cohorts was
conferred predominantly by six different ribosomal protection genes identified through
tetracycline functional selections and beta-lactam resistance was dominated by high recovery of
CfxA4, a beta-lactamase. Captive apes had up to ~34-fold higher abundance and up to ~5-fold
higher richness of all ARGs compared to wild apes (Figures 3-3D,E). The most parsimonious
explanation for the higher observed burden of ARGs in captive apes compared to wild apes is the
higher selection pressure from antibiotic treatment of the captive apes. We had limited access to
antibiotic treatment records for captive apes but the records we do have indicate that captive apes
received on average 1.7 antibiotic treatments per year providing ample selection for ARGs.
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Congolese human microbiomes had the highest abundance and richness of ARGs with ~3-fold
higher abundance and ~2-fold higher richness compared to the next highest cohort (Figures 33D,E). Host lifestyle appears to be the driving force for ARG abundance and richness in these
analyses.

Figure 3-3: The antibiotic resistome of humans, chimpanzees, and gorillas. (A) PCoA plot
using Bray-Curtis distances of ARG abundance normalized with RPKM from ShortBRED results
of human, chimpanzee, and gorilla resistomes. (B) PCoA plot using Bray-Curtis distances of ARG
richness (presence/absence) from ShortBRED results of human, chimpanzee, and gorilla
resistomes. (C) Relative abundances of major classes of antibiotic resistance averaged by host
cohort. (D) Sum of all ARG marker abundances per metagenome based on markers generated from
the CARD database and functional selections, expressed in log transformed RPKM (KruskalWallis sum-rank test P < 2.2e-16; Wilcoxon rank sum test with Benjamini-Hochberg correction P
1.2e-5). (E) Resistome richness per metagenome (Kruskal-Wallis sum-rank test P < 2.2e-16;
Wilcoxon rank sum test with Benjamini-Hochberg correction P 0.049). (F) Alignment of an
ARG containing DNA fragment with high similarity across host cohorts obtained from functional
metagenomic selections. (G) Histogram of amino acid identity to known ARGs for aminoglycoside
resistance genes identified through functional metagenomic selections. Colors indicate from which
host libraries each gene was isolated.
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3.3.4 Functional metagenomic selections identified novel antibiotic resistance
genes
One major advantage of functional metagenomic analysis is the ability to identify novel
ARGs from metagenomic DNA without the need for high sequence identity to known ARGs [12,
151, 163]. This allows for the characterization and surveillance of identified ARGs before they
become clinically disseminated [163, 167, 193]. Since wild ape resistomes were dominated by
aminoglycoside resistance, we explored proteins annotated as aminoglycoside resistance from our
functional selections on ape microbiomes. From these selections, we identified 19 aminoglycoside
resistance methyltransferases that belonged to the FmrO family. When compared to known ARGs
in the CARD database, we found that they all aligned to 16S rRNA methyltransferases, such as
rmtC, rmtD, rmtF, rmtH, or sgm. The percent similarity of these genes to known ARGs ranged
from 29-98%, indicating that some of these genes have not been identified previously (Figure 33G).
Additionally, we found a total of nine contigs from functional metagenomic selections
containing ARGs that were shared either across host species or captivity status demonstrating that
Congolese human microbiomes harbor some of the same ARGs as wild and captive ape
microbiomes (Figures 3-3F, 3-S4). One ~2 kb contig that was particularly widespread between
different hosts contained a PenP beta-lactamase located between two mobile elements, an
integrase and a tnpR resolvase, indicating a high potential for horizontal gene transfer [194, 195].
Highly similar copies (>99% similarity) of this PenP-containing contig were found in functional
libraries created from every research cohort in this study except for wild chimpanzees. This gene
may be widespread either because it is contained in a widespread bacterial taxon, has spread to
several bacterial taxa through horizontal gene transfer, or a combination of these factors. Out of
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the nine PenP-containing contigs identified, three contained ARGs co-localized with mobile
elements. Identification of ARGs in captive and wild apes indicates that ape microbiomes may
serve as a zoonotic reservoir of antibiotic resistance that may be exchanged with human associated
microbes [169]. Importantly, identification of similar ARGs in human and ape populations also
indicates that the human microbiome may serve as a reservoir for ARG acquisition by great ape
microbiomes. Transmission of microorganisms between humans and great apes in both directions
is well documented, with several pathogens exhibiting zoonotic or anthropozoonotic patterns [154,
156-159, 171, 183, 196, 197]. Transmission of microorganisms also results in transfer of the ARGs
that those organisms contain. Identification and characterization of reservoirs of ARGs in humans
and other closely related Hominidae species, including wild and captive populations, allows for a
proactive approach to combat antibiotic resistance via surveillance and targeted infection control
measures [198-200]. These transmission events are likely to rise as humans and great apes are
increasingly brought into contact with each other through ecotourism, human population growth
near conservation areas, and civil unrest [154, 156, 183, 201, 202].
We also identified an ARG conferring resistance to colistin, an antibiotic of last-resort,
from a Congolese human derived functional metagenomic library (Figure 3-S3A). The identified
contig contained a gene annotated as a member of the type 2 phosphatidic acid phosphatase (PAP2)
superfamily that, when isolated and expressed in a pZE21 plasmid backbone, conferred a minimal
inhibitory concentration of 4 µg/ml to colistin in E. coli. This represents an ~85-fold increase in
resistance compared to the empty vector control (Figure 3-S5A). An MIC of 4 µg/ml exceeds the
2 µg/ml resistant/susceptible breakpoint in Enterobacteriaceae according to the European
Committee on Antimicrobial Susceptibility Testing (EUCAST), indicating this level of resistance
could have implications if this gene were transmitted to human pathogens. Colistin works by
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targeting the lipid A portion of lipopolysaccharide leading to disruption of the outer cell membrane
and ultimately cell death [203]. Resistance is typically conferred by modification of lipid A by
addition of chemical moieties to LPS, preventing colistin binding. For example, a clinically
relevant colistin resistance gene, mcr-1, provides colistin resistance by adding a
phosphoethanolamine moiety to LPS [198]. We predict that the PAP2 gene from this study either
alters LPS by adding a chemical moiety onto LPS or by altering the composition of the cell
membrane to include less LPS.
Using BLAST, we identified two proteins similar to the PAP2 gene product in the NCBI
non-redundant protein database. One was discovered from published functional metagenomic
selections on colistin [163] (98.62% identity and 76% coverage) and the other came from a
Prevotella sp. genome assembled from metagenomic samples [204] (98.88% identity and 95%
coverage) (Figure 3-S5B). After these two similar proteins there is a sharp drop in identity with
the next closest proteins also coming from Prevotella hosts (Figure 3-S5B). Bacteria from the
genus Prevotella are generally considered to be commensal to humans, so colistin resistance in
this genus is not particularly troublesome. However, continued usage of colistin increases the
selection pressure and possibility of horizontal gene transfer of this gene to pathogenic strains.
Indeed, mcr-1 originated from non-pathogenic species within the genus Moraxella and has since
spread to human and animal pathogens in the Enterobacteriaceae family [205-207]. The
identification of this PAP2 colistin resistance gene from a functional metagenomic selection allows
time for the characterization and surveillance of this gene before it is transmitted to human or
animal pathogens.

3.3.5 Captive ape microbiomes and resistomes cluster closely with nonWesternized humans
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To contextualize the microbiomes from our cohorts within a diverse group of human
lifestyles and environments, we compared our samples to publicly available human and ape gut
microbiomes. We included sequencing data that also targeted the V4 region of the 16S rRNA gene
from Westernized and non-Westernized humans. Westernized humans include data from humans
in the USA [144] (n = 20) and a peri-urban slum of Lima, Peru [163] (n = 20). The nonWesternized humans can be grouped into a rough gradient of Westernization with the human
cohort from this study in the Republic of the Congo (n = 81), rural farmers in El Salvador [163] (n
= 20) and farmers in Malawi [144] (n = 20) having intermediate Westernization, and Hadza huntergatherers [170] (n = 20) and Guahibo Amerindians [144] (n = 20) being the least Westernized. We
also included a study of great ape microbiomes that used the V4 region of the 16S rRNA gene that
analyzed captive gorillas from zoos in the USA, France, and Switzerland [175] (n = 8). Analysis
of the microbial composition of the gut microbiome by PCoA resulted in Westernized and nonWesternized humans clustering by lifestyle despite differences in geographic location. Contrary to
our initial hypothesis that non-human primates would cluster with humans living near them,
captive apes clustered near the non-Westernized humans that shared a similar lifestyle, and wild
apes clustered separately (Figures 3-4A, 3-S6A). Some samples of the published captive gorilla
cohort clustered with our captive gorillas while others were intermediate between captive and wild
apes. Alpha diversity, as measured by ASV richness and Shannon diversity, demonstrated no
apparent pattern of westernization, but USA humans did have the lowest richness and among the
lowest Shannon diversity, as has been demonstrated previously (Figure 3-4B, 3-S6C) [142, 183,
208]. Overall, we observed that the patterns of clustering we observed in our initial analysis are
robust to further differences in host geography.
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We accessed published shotgun metagenomic sequencing data from similar human and
gorilla cohorts for resistome and functional pathway analysis. Westernized human sequencing data
was obtained from humans in Norman, USA [146] (n = 20) and the peri-urban slum in Lima, Peru
[163] (n =14). Non-Westernized humans included the Tunapuco community in the Peruvian
Andean highlands [146] (n = 10), rural farmers in El Salvador [163] (n = 9), Hadza huntergatherers from Tanzania [147] (n = 20), and humans from this study in the Republic of the Congo
(n = 81). We also included a cohort of wild gorillas (n = 19) from the Sangha region of the Republic
of the Congo, a sample site with higher human disturbance [140] than our study site that is ~200
km away. By obtaining shotgun metagenomic sequences we were able to compare differences in
the gut microbiome functional pathways and resistome.
Functional pathways were robust to differences in geographic location with captive apes
continuing to cluster between wild apes and humans (Figures 3-4C, 3-S6C). All human cohorts
clustered closely together despite coming from different countries throughout the world. In fact,
there was no significant difference in the compositions of the Hadza and Tunapuco cohorts
(pairwise adonis, P = 0.08) and between the Tunapuco and El Salvador cohorts (pairwise adonis,
P = 0.06). Wild chimpanzees and wild gorillas also had no significant differences in gut
microbiome composition (pairwise adonis, P = 0.42). The gorillas from the Sangha region
generally clustered with wild ape samples from this study with a few samples clustering separately,
possibly representing samples from different seasonal diets not represented in our data [140].
Overall, all samples had decreased Bray-Curtis distances compared to taxonomic distances, most
likely due to redundant functional pathways found across microbial taxa (Figure 3-S6C).
Resistome composition generally clustered by degree of Westernization but had less clear
separation between Westernized and non-Westernized humans than taxonomic analysis (Figures
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Figure 3-4: Comparison of chimpanzee and gorilla microbiomes to human microbiomes
across a wide range of lifestyle and environment. (A) PCoA plot of Bray-Curtis 16S
metagenomic profiles. (B) ASV richness of host human, chimpanzee, and gorilla microbiomes
(Kruskal-Wallis sum-rank test P < 2.2e-16; Wilcoxon rank sum test with Benjamini-Hochberg
correction P 0.021). (C) PCoA plot using Bray-Curtis distances of the relative abundance of
functional pathways from HUMAnN2 results. (D) PCoA plot of Bray-Curtis distances of ARG
abundance normalized with RPKM from ShortBRED results. Two wild chimpanzee samples and
one wild gorilla sample were removed from this PCoA analysis because the lower rarefaction level
used for comparison with public data resulted in no ARGs detected for these samples and no BrayCurtis distances could be calculated. (E) Sum of all ARG marker abundances per metagenome
expressed in log transformed RPKM (Kruskal-Wallis sum-rank test P < 2.2e-16; Wilcoxon rank
sum test with Benjamini-Hochberg correction P 0.034). (F) Resistome richness per metagenome
(Kruskal-Wallis sum-rank test P < 2.2e-16; Wilcoxon rank sum test with Benjamini-Hochberg
correction P 0.049).
3-4D, 3-S6D). Captive chimpanzee and captive gorilla resistomes were not significantly different
from each other (pairwise adonis, P = 0.23) and the wild chimpanzee, wild gorilla and Sangha
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gorilla resistomes were not significantly different from each other (pairwise adonis, wild
chimpanzee vs. wild gorilla, P = 0.63, wild chimpanzee vs. Sangha gorilla, P = 0.18, wild gorilla
vs. Sangha gorilla, P = 0.10) demonstrating that host species is less influential in resistome
composition than lifestyle.
Hadza hunter-gatherers had the highest ARG abundance of all groups analyzed, followed
by the other human cohorts, captive apes, and then finally wild apes with the lowest abundance
(Figure 3-4E). All the human cohorts from developing countries had high ARG richness with wide
variance except for the El Salvador human cohort (Figure 3-4F). Antibiotic resistance may be high
in developing countries for a number of reasons, including: a high burden of infectious disease,
poor sanitation, and less regulation of antibiotic compounds [209]. Wild apes had the lowest levels
of ARGs with captive apes also generally having lower levels of ARG richness and abundance
than humans. Lifestyle may be the most influential factor of resistome composition, but host
species appears to play a role in ARG alpha-diversity metrics.
In conclusion, contrary to our hypothesis sympatric hosts did not have the most similar gut
microbiome composition. Host lifestyle appears to be more influential than host geography or host
species at structuring taxonomic and resistome composition. However, functional pathway
composition and alpha-diversity metrics of taxonomy and the resistome appear to be influenced
by host species and geography. Further, captive ape microbiomes clustered with non-Westernized
humans despite living in close proximity to Westernized humans. Our findings indicate that the
microbiome of closely related host species may be molded by changes in diet and the degree of
antibiotic usage despite the geographic location.
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3.4 Materials and Methods
3.4.1 Sample Collection
Wild ape fecal samples were collected in the Goualougo Triangle region of NouabaléNdoki National Park in the Republic of the Congo. Samples were collected in the morning from
overnight nesting sites from habituated chimpanzees and gorillas and matched to metadata for the
animal that occupied the nest. Human samples were collected from humans living outside of the
national park boundaries, including and surrounding the village of Bomassa. Captive ape samples
were collected from the Lincoln Park Zoo and the St. Louis Zoo. All sample collection was
performed with informed consent for the human participants and in accordance with ethics
approval by le Comité d’Ethique de la Recherche en Sciences de la Santé (CERSSA) in the
Republic of the Congo. Samples were kept in cold storage on dry ice until shipment to Washington
University in St. Louis, where they were stored at -80 °C until processing.

3.4.2 DNA Extraction and Library Preparation
DNA was extracted from 100 mg of each fecal sample using a PowerSoil DNA Isolation
Kit (MoBio) with a Mini-beadbeater (BioSpec Products) for the lysis step and stored at -20 °C.
Target metagenomic sequencing libraries were created by amplifying the V4 region of 16S rRNA
genes using 515F-806R barcoded primers and PCR protocols described previously [210]. Barcoded amplicons were pooled and sequenced on an Illumina MiSeq sequencer with 2 × 250-bp
paired-end reads. Shotgun metagenomic sequencing libraries were prepared by diluting extracted
DNA to 0.5 ng/µl and using a Nextera DNA Library Prep Kit (Illumina) following the
modifications described in Baym et al. to generate ~450 bp segments [122]. DNA fragments were
then purified using the Agencourt AMPure XP system (Beckman Coulter) and quantified using
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the Quant-iT PicoGreen dsDNA assay (Invitrogen). For each sequencing lane, 10 nM of
approximately 80 samples were pooled three independent times. The resulting pools were
quantified using the Qubit dsDNA BR Assay and equimolar concentrations were combined.
Samples were sequenced on an Illumina NextSeq High-Output platform at the Edison Family
Center for Genome Sciences and Systems Biology at Washington University School of Medicine
in St. Louis, with a target sequencing depth of 4 million 2 × 150-bp paired-end reads per sample.

3.4.3 16S and shotgun metagenomics bioinformatics analysis
Barcoded 16S Illumina reads were demultiplexed and barcodes were removed using
QIIME v1.9 [174]. No significant differences were found in sequencing depth between host
cohorts, so samples were not rarefied (Kruskal-Wallis, P = 0.18; Figure 3-S1C). Phylogenetic
analysis was performed using dada2 v1.8 [211] according to the recommended pipeline. The
resulting ASVs were assigned taxonomy using the Greengenes database [212] (version 13_8, 97%
clusters). Principal Coordinate Analysis plots were generated using Bray-Curtis distances on
sequence counts normalized by relative abundance and significance testing was performed using
Adonis. No normalization was performed before alpha-diversity analysis. Significance testing for
alpha-diversity was performed using the non-parametric Kruskal-Wallis Rank Sum test and the
Pairwise Wilcoxon Rank Sum test using the Benjamini-Hochberg correction for multiple testing.
Groups were considered significantly different if the resulting P-value was less than 0.05.
Shotgun reads were trimmed for quality and to remove sequence adapters using
Trimmomatic v0.38 [124] with the following parameters: trimmomatic-0.38.jar PE -phred33
ILLUMINACLIP:

NexteraPE-PE.fa:2:30:10:1:TRUE

LEADING:10

TRAILING:10

SLIDINGWINDOW:4:15 MINLEN:60. Host reads were then removed using DeconSeq v0.4.3
[213, 214] by mapping to the respective host genome (GRCh38 for human; Pan troglodytes,
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GCA_000001515.5, panTro5 for chimpanzee; Gorilla gorilla gorilla, GCA_900006655.1,
gorGor5 for gorilla). To normalize for sequencing depth, all samples were rarefied to 4 million
paired-end reads. For functional pathway analysis, we used HUMAnN2 v0.9.4 [35] to calculate
relative abundance of annotated microbial gene pathways in the MetaCyc database [215]. Since
HUMAnN2 does not take paired-reads into account, forward and reverse paired-end reads were
combined.

The

resulting

output

was

normalized

to

copies

per

million

(CPM)

(humann2_renorm_table) and samples were joined into a combined table (humann2_join_tables).
Downstream statistical analysis was performed in R. Bray-Curtis distances and Adonis
significance testing were computed using the vegan package [216]. All of the box and whisker
plots represent the 1.5×interquartile ranges in the boxes, medians (50th percentiles) are indicated
by the bars within the boxes, the whiskers below and above the box indicate the 10th and 90th
percentiles, and the outliers beyond the whiskers are indicated with black circles if all data points
are not shown. All statistics for boxplot analyses are based on Kruskal-Wallis tests and if
significance is indicated two-tailed P-values were calculated using the Wilcoxon rank sum test.

3.4.4 Functional metagenomics and analysis
Due to a limited amount of metagenomic DNA available from individual samples, we
pooled samples within host groups to create 16 separate functional libraries (Supplementary Table
3-1). Functional metagenomic libraries were prepared and created as previously described [12].
Briefly, small-insertion (~3-6 kb) expression libraries were created from 5 µg of pooled
metagenomic DNA in vector pZE21 and transformed into E. coli MegaX DH10B electrocompetent
cells. We screened libraries on Mueller-Hinton agar plates containing 12 natural and synthetic
antibiotics from 6 different antibiotic classes at concentrations empirically determined to inhibit
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the growth of non-transformed MegaX cells. PCR was performed on pooled resistant colonies with
vector-specific primers, barcoded, and sequenced.
Sequenced reads were filtered, demultiplexed, and assembled into contigs with PARFuMS
v1.1 [167]. We removed all contigs from selections where the number of contigs was more than
ten times the number of colonies that grew on the selective agar. Contigs smaller than 500 bp were
also removed from further analysis and ORFs were annotated using Resfams v1.2 [217]. We
identified 887 contigs which resulted in 332 ORFs that could be classified with high confidence
as ARGs related to the screened antibiotic class. Using ShortBRED v0.9.4 [36], we clustered
identified ARG protein sequences from functional metagenomic selections and ARG protein
sequences from the CARD database [188] with a cluster identity of 90% and used Uniref90 as a
reference database for marker creation. We generated 3,092 unique markers for 907 ARG clusters.
To measure the abundance of these markers, relative abundance tables normalized to RPKM were
created using the shortbred_quantify.py script to identify ARG markers in the shotgun
metagenomic reads from all our samples.

3.4.5 Microbiome and resistome comparisons to published cohorts
For 16S external analysis, we downloaded public sequencing data of the V4 region of the
16S rRNA gene from subsistence farmers in El Salvador [163], Hadza hunter-gatherers [170],
Amerindians [144], and cohorts living in the USA [144], Malawi [144], a peri-urban shanty-town
in Lima, Peru [163], and captive gorillas from zoos in the USA, France, and Switzerland [175].
Downloaded data was combined with sequencing reads from this study and all 16S DNA
sequences were trimmed to 100 bp to match the length of the shortest downloaded sequences.
Samples were rarefied to 9,800 single end reads and the same metagenomics analysis was
performed as described above.
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For shotgun analysis, we downloaded public shotgun sequencing data from subsistence
farmers in El Salvador [163], Hadza hunter-gatherers [147], and cohorts living in the USA [146],
Tunapuco, Peru [146], a peri-urban shanty-town in Lima, Peru [163], and wild gorillas from the
Sangha region of the Republic of the Congo [140]. After removing all samples from individuals
less than 3 years old we randomly selected up to 20 samples from each cohort. We checked for
adapters using FastQC v0.11.7 [218]. The sequencing reads appeared to be of good quality and
contained no adapters, so we removed host reads using DeconSeq and the human reference genome
listed above. The public data contained several samples with less than four million reads, the cutoff
used for analysis of Congo humans and wild and captive apes above, so samples were rarefied to
three million reads and samples with less than three million reads were removed from analysis.
DNA sequencing reads were trimmed to 100 bp to match the length of the shortest downloaded
sequences. Some cohorts only had single-end reads so only forward reads were used from pairedend data. Functional analysis was performed using HUMAnN2 as described above. Resistome
analysis was performed using ShortBRED with the same parameters as above.

3.4.6 Colistin resistance analysis
The PAP2 gene identified in the functional metagenomic selections was synthesized into
the pZE21 vector by Synbio Technologies (Monmouth Junction, NJ). The plasmid was
transformed into E. coli DH10B and MIC testing was performed using a Colistin ETEST strip
(bioMérieux Inc) and confirmed in triplicate using ComASP Colistin Broth Microdilution
Susceptibility Testing plates (Liofilchem).

3.4.7 Data availability
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16S rRNA and shotgun metagenomic Illumina sequencing data of human, chimpanzee, and
gorilla

samples

is

available

from

the

Sequence

Read

Archive

(SRA)

under

accession PRJNA539933. 16S rRNA data is de-multiplexed and trimmed. Shotgun metagenomic
data is de-multiplexed, trimmed, quality-filtered, and host reads have been removed.
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3.5 Supplemental Figures

Figure 3-S1: Discriminating taxonomic changes in captive and wild apes. (A) Heatmap of
Bray-Curtis distances between host cohorts. (B) Alpha diversity of humans, chimpanzees, and
gorillas calculated using Shannon diversity (Kruskal-Wallis P = 8.9e-6; Wilcoxon rank sum test
with Benjamini-Hochberg correction P 0.0076). (C) Boxplot of 16S sequencing depth (KruskalWallis P = 0.18) (D) Cladogram of discriminatory taxa identified in captive and wild chimpanzees
(LEfSe LDA log score >4.5, P = 0.05). (E) Cladogram of discriminatory taxa identified in captive
and wild gorillas (LEfSe LDA log score >4.5, P = 0.05).
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Figure 3-S2: Functional pathway analysis of host microbiota. (A) Heatmap of Bray-Curtis
distances of functional pathways. (B) PCoA pot of Bray-Curtis distances of the relative abundance
of functional pathways from HUMAnN2 results for chimpanzees and gorillas. (C) Discriminatory
functional pathways identified in captive chimpanzees (CC), captive gorillas (CG), humans, wild
chimpanzees (WC), and wild gorillas (WG) (LEfSe log score > 3.5, P = 0.05).
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Figure 3-S3: Functional metagenomic resistome analysis of humans chimpanzees and
gorillas. (A) Heatmap showing functional metagenome growth results on selective media. Blue
squares indicate that colonies were present and white squares indicate no growth was present.
Functional libraries are named as described in Supplementary Table 1. (B) PCoA of Bray-Curtis
distances of ARG abundance of chimpanzee and gorilla normalized with RPKM. (C) PCoA plot
of Bray-Curtis distances of ARG diversity (presence/absence) of chimpanzee and gorilla
resistomes. (D) Heatmap of Bray-Curtis distances of ARG abundance using Bray-Curtis distances
normalized with RPKM. e, Heatmap of Bray-Curtis distances of ARG diversity
(presence/absence).
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Figure 3-S4: Alignments of ARG containing DNA fragments with high similarity across host
cohorts from functional metagenomic selections. (A-H) The library from which the contig
originated is indicated.
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Figure 3-S5: Endogenous expression of colistin ARG is highly resistant to colistin. (A) MIC
of colistin against empty vector (EV) control and the novel colistin resistance protein (CL H8). (B)
Phylogenetic tree of the colistin resistance protein to the closest BLAST hits from the NCBI nonredundant protein database accessed May 18, 2019. Percent identity and percent coverage are
given for each protein in comparison to CL H8.
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Figure 3-S6: Comparison of ape microbiomes to human microbiomes along a gradient of
Westernization. (A) Heatmap of Bray-Curtis distances of 16S microbiome data normalized using
relative abundance. (B) Shannon diversity of apes and humans along a gradient of Westernization
(Kruskal-Wallis P = 1.5e-6; Wilcoxon rank sum test P 0.049). (C) Heatmap of Bray-Curtis
distances of functional pathway abundance normalized using counts per million. (D) Heatmap of
Bray-Curtis distances of ARG abundance normalized using RPKM. For this analysis one wild
chimpanzee sample had no identified ARGs and was subsequently removed from distance analysis
since no Bray-Curtis distance could be calculated.
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Table 3-S1: Pooling scheme for functional metagenomic library preparation. Metagenomic
DNA was pooled to create 5 µg expression libraries. Extractions with low concentrations required
pooling of more samples to achieve a final DNA yield of 5 µg.
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Chapter 4

Conclusions and Future directions
4.1 Lignocellulose degradation by R. opacus
In Chapter 2, we identified aromatic funneling enzymes and transporters present in R.
opacus through a combination of RNA-seq and protein identity. Identification of these enzymes
allows for the enhancement and possible introduction of these genes into other bacterial strains
used for biofuel production. Identification of degradation enzymes across various microbial taxa
increases the toolbox available for strain engineering that can then be introduced into wild type R.
opacus strains in order to optimize biofuel production. This engineering can be further guided by
metabolite profiling and metabolic flux analysis that was recently published [219].
Further, through adaptive evolution we found, surprisingly, that none of the mutations
found in strains adapted on phenolic compounds were located in genes involved directly in
degradation of phenolic compounds. The two genes found in the most strains, superoxide
dismutase and cytochrome ubiquinol oxidase subunit I, are involved with redox reactions.
Superoxide dismutase quenches radical oxygen species by converting them to either oxygen or
hydrogen peroxide molecules, hydrogen peroxide can then be further degraded to oxygen and
water [118]. Increased activity in this protein may help counteract the radical oxygen species that
are created in aromatic xenobiotic toxicity. However, we found the opposite to be true: the adapted
strain containing the mutated superoxide dismutase had increased radical species in the cell
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indicating reduced activity in the mutated superoxide dismutase. We hypothesize that the increased
amount of superoxide radicals allows for faster oxidation of the phenolic aromatics since
degradation enzymes have to generate superoxide radicals to catabolize aromatic compounds [101,
102]. In consort with this, mutations in the cytochrome ubiquinol oxidase subunit I may also
increase the concentration of oxygen species within the cell, making them available for aromatic
oxidation. Cytochrome ubiquinol oxidase is the last stage of the electron transport chain, and its
main function is the final step where electrons are loaded onto oxygen species, reducing them to
water [119]. Less efficient activity of this enzyme should thus result in increased oxygen species
within the cell but with a cost: some energy is lost from decreased activity of the electron transport
chain. However, we did not measure the activity of cytochrome ubiquinol oxidase directly, and it
is possible that the mutations introduced into this enzyme enhanced the enzyme activity. Future
work can be performed to determine if the introduced mutations increased or decreased enzyme
activity.
This study’s limitations included the use of model lignin breakdown products instead of
real-world lignin and the difficulty of making genetic alterations in R. opacus. The aromatic
compounds used in this study are only a few of the large moiety of aromatics created during lignin
depolymerization. Depolymerized lignin was not used in this study due to limited production
capabilities and the tendency of depolymerized lignin mixtures to degrade over time. Although the
use of simplified model compounds was not ideal, it provided consistent selective pressure for the
adaptation experiments, and the resulting findings can be applied to engineer a strain for lignin
depolymerization products. Also, at the time of this project, we did not have the tools necessary to
make single nucleotide alterations in the R. opacus genome, so we were unable to determine the
effect of each individual mutation in isolation. Thus, we don’t know which mutation or
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combinations of mutations are contributing the most to the increased aromatic tolerance
phenotype. Further work is necessary to introduce these mutations into the WT background of R.
opacus to determine the relative contribution of each of the SNPs that we found in adapted strains.
However, characterization of all 255 distinct SNPs is impractical, so initial analysis could be
simplified by targeting the SNPs that occurred across more than one adaptation experiment (see
Fig. 2-3B).

4.2 Antibiotic resistance in human and ape microbiomes
In Chapter 3, we found that antibiotic treatment and captivity is associated with an increase
in antibiotic resistance gene (ARG) richness and abundance. The increased presence of ARGs in
antibiotic-treated hosts supports the hypothesis that antibiotic usage selects for resistant bacteria.
The abundance of resistance genes increases as resistant bacteria start to dominate the community
and as ARGs are disseminated to otherwise susceptible strains through horizontal gene transfer
(HGT). We found evidence that some ARGs are shared across host species, even when the hosts
are geographically distant. These shared ARGs are found within similar genetic contexts, with
some genes being colocalized next to mobile elements, indicating an increased propensity for
HGT. These genes may have spread across host microbiomes through transfer from one bacterial
strain to another. However, we can’t rule out the possibility that these individual ARGs may be
found in a bacterial species that is shared across the microbiomes and thus inherited vertically
rather than horizontally.
We identified several novel ARGs through our functional metagenomic selections. These
genes included resistance to a number of antibiotics, including aminoglycosides and colistin, an
antibiotic of last resort [198]. Discovery of novel ARGs provides the opportunity to characterize
these genes before they become clinically relevant. The discovery of a new class of tetracycline
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resistance genes, termed the tet destructases, from functional metagenomic selections provides a
great example of the power of this method. These ARGs were initially discovered in environmental
soil samples and have now been characterized [52, 193]. This initial characterization has led to the
development of tet destructase inhibitors that rescue tetracycline antibiotics from these resistance
genes [220]. Inhibition of tet destructase enzymes is increasingly relevant to human health
outcomes because tet destructases have now been found in human pathogens [221, 222]. The
discovery and characterization of tet destructases provides an ideal example for how ARG
surveillance can lead to clinically relevant outcomes. However, The functionally identified novel
resistance genes from this study and several other studies has mostly been ignored with little to no
follow up studies on the novel ARGs identified [54, 151, 163, 223]. The colistin resistance gene
identified in this study provides a good candidate for further characterization. Future research can
be performed to characterize the mechanism of resistance and to determine if this gene can confer
colistin resistance in human pathogens such as Acinetobacter baumannii. Further work can
categorize these novel ARGs by finding all of the ARGs identified in these studies with similar
antibiotic targets and mechanisms (e.g. the aminoglycoside methyltransferases or beta-lactamases)
and creating phylogenetic trees to visualize the divergence of these genes from known ARGs
within the categories. After distinct groupings are identified, representative genes can be assayed
to confirm the resistance phenotype and further characterization can be performed on the genes
most dissimilar to known resistance genes. This approach will lead to a better understanding of
ARG diversity and may provide insight to guide ARG inhibition in the future.

4.3 General Conclusion
In individual isolates equipped with xenobiotic degradation genes, xenobiotics selected for
unexpected cellular mechanisms that improved degradation efficiency. These cellular
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modifications may be harnessed to create an optimized strain through genetic engineering. In
microbial communities with varying levels of xenobiotic tolerance genes, antibiotic selection
pressure was associated with an increased abundance of tolerance genes within the community,
highlighting the dangers of antibiotic overuse. Overall, knowledge of xenobiotic tolerance in
bacteria can be harnessed to benefit industrial processes and protect human health.
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